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Introduction and short summary 
 
26-28 May 2010 the 14th annual meeting of the National Reference Laboratories for fish diseases 
was held back-to-back with a Workshop on “Use of Diagnostic Kits for Detection of Fish 
Diseases”. A total of 65 participants from 35 countries attended over the three day period. There 
were five sessions with a total of 41 presentations, 9 of which were given by invited speakers. The 
workshop and meeting was held at rented nearby facilities of Aarhus University, as the premises at 
our institute in Aarhus are too small for the number of participants.    
 
The workshop on “Use of Diagnostic Kits for Detection of Fish Diseases” was held the day before 
the Annual Meeting. Many different kits are available for detection of fish pathogens and in the 
future more will come. Besides providing a presentation of some of the kits that are currently 
available on the market, the aim of the workshop was to discuss how laboratories can ensure that 
commercial as well as own diagnostic kits are properly validated. The workshop started with a 
presentation on the outcome of the survey and diagnosis questionnaire on what kits are used by the 
NRLs for detection of fish pathogens. Subsequently, a talk on general needs on development and 
validation of diagnostic tools were presented. The procedures for tests of different commercial 
antibody based kits were described in four talks by four speakers from different 
laboratories/companies. The last two sessions were focused on molecular biological tools. A DNA-
array based diagnostic tool followed by the LAMP originated kits was presented. The workshop 
was ended by a plenum discussion on how laboratories should ensure properly validation of used 
diagnostic kits. Discussions continued in the evening where all participants were invited to a drinks 
reception at the National Veterinary Institute. 
 
The scientific programme of the Annual Meeting was diverse and covered many topics of current 
interest. The meeting was opened with the traditional session on update of fish diseases in Europe, 
where once again participants from the member states presented new findings from their home 
countries. Initially an overview of the disease situation and surveillance in Europe 2009 were 
provided on the basis of the results from the survey and diagnosis questionnaire. Scotland UK 
updated on the situation after the outbreak of ISA in 2009. Results of a questionnaire send to 12 
fish-pathology experts was the basis of a presentation on old and emerging diseases from the 
Mediterranean aquaculture.  Subsequently a talk on multiple infected fish in a Swiss fish farm was 
presented, followed by a talk on the VHSV eradication program in Denmark. Later in this session 
presentations about pancreas disease and BKD from Norway and Red Mark Syndrome and the 
Rosette Agent were given. The session was ended by a talk on bio-security risk associated with 
EUS and Iridovirus in ornamental fish. 
 
The session on technical issues related to sampling and diagnosis were divided into two parts. The 
first session focussed on the new EU manuals on sampling and diagnostic procedures that will be 
uploaded on the www.crl-fish.eu web page later this year. Here diagnostic procedures for detection 
of the listed non-exotic fish pathogens VHSV, IHNV, ISAV and KHV as well as the exotic EHNV 
and EUS were described.  
The last part of this section focussed on many different issues. It was initiated with two talks on un-
explained increased mortality: how to deal with it from a legislative and a practical perspective, 
respectively. Later talks were focussed on sensitivity and specificity of test procedures for BKD, 
non-lethal sampling and KHV detection in latent infected koi carps, identification of a possible 
novel Cyprinid herpesvirus 3 variant strain and a novel real-time PCR assay to detect VHSV. 
 
In the evening a banquet dinner was held at Restaurant “MellemRum”, located downtown Aarhus. 
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The last day was opened by an update session on scientific research. At this session, presentations 
were given on progress in the development in sero-neutralisation test for detection of antibodies 
against KHV in carp, on vertical transmission of pancreas disease (PD) and infectious salmon 
anaemia (ISA), respectively, and on the findings that heart and skeletal muscle inflammation 
(HSMI) most likely is caused by a reovirus. Subsequently two projects were presented: the Club 5 
project on EUS diagnostic methods and the NADIR project on access to infection facilities. The 
session was closed with a presentation on 1) perch rhabdovirus infection in perch and pike-perch 
and 2) the putative use of miRNA in future diagnostics.  
 
The annual meeting ended with the traditional update from the CRL. The results of the proficiency 
test 2009 were presented. A report from year 2009 was given, a year with focus on training of 
laboratories and thoughts and considerations about preparation of the new EU diagnostic manuals. 
Furthermore, proposals on the CRL work plans for 2011 were discussed. 
 
Minutes from the meeting were taken by Helle Frank Skall, Søren Peter Jonstrup, Torsten Boutrup 
and Søren Kahns, and have afterwards been sent to presenters for correcting in order to avoid 
misunderstandings. The minutes are included in this report together with abstract and comments 
from the presentations. Nicole Nicolajsen assembled the report.  
 
We would once again like to thank all the presenters for their great contribution without which the 
meeting would not have been a success. 
 
The workshop and meeting was organised by a team consisting of Søren Kahns, Niels Jørgen 
Olesen, Helle Frank Skall and Nicole Nicolajsen, with the help from the rest of the fish disease 
section at DTU Vet.  
 
The meeting next year is tentatively planned to be in week 21, most likely from 24-26 May 2011 
but more details will follow. 
 
We wish to thank all of you for participating and look forward to seeing you next year! 
 
 
Århus, 28 June 2010 
 
 
Niels Jørgen Olesen and Søren Kahns 
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Programme 
 
Wednesday 26 May  
Workshop on Use of Diagnostic Kits for the Detection of Fish Diseases 
 
9:00 – 10:00 
 
Registration, welcome address and announcements 
 Chair: Giuseppe Bovo  
10:00 – 10:20  Welcome Address and announcements - Søren Kahns and  Niels Jørgen Olesen 
10:20 – 10:50 Use of diagnostic kits and reagents in the European NRLs, presentation of data from 
the “survey and diagnosis” questionnaire 2009 - Niels Jørgen Olesen 
10:50 – 11.20 Diagnostic tools: Development and validation of tests for detection of viral fish 
diseases – Niels Jørgen Olesen 
11:20 – 11:50 Development and Validation of a Lateral Flow Kit to detect ISAV - Alexandra Adams 
11:50 – 13:20 Lunch Break + Presentation of products by companies 
13:20 – 13:40 Test-Line kits for the detection of fish pathogens -  Tomas Vesely 
13:40 – 14:00 Development and assessment of reagents and diagnostic kits from BioX used in the 
NRL for Fish Diseases in Germany - Sven M. Bergmann 
14:00 – 14:20 Specificity and sensitivity testing of diagnostic kits from commercial companies at 
the CRL - Helle Frank Skall 
14:20 - 15:00 Coffee Break + Presentation of products by companies 
 Chair: Søren Kahns 
15:00 – 15:30 DNA-array based diagnostics: Applications in fish disease diagnosis – Ingeborg 
Frans & Bart Lievens 
15:30 – 15:50 Experiences from using LAMP originated kits in KHV diagnostics in comparison to 
other tools - Sven M. Bergmann 
15:50 – 16:20 Plenum discussion  
16:20 – 17:00 Presentation of products by companies  
 17.00 – 18.30 
 
Drinks reception  
Sponsored by: 
 
 
 
 
 
Thursday  27  
May - Annual Meeting of the National Reference Laboratories  
 
8:30 – 9:00  
 
 
Registration, welcome address and announcements 
Niels Jørgen Olesen and Søren Kahns 
SESSION I: Update on important fish diseases in Europe and their control 
 Chair - Brit Hjeltnes 
9:00 – 9:30 Overview of the disease situation and surveillance in Europe in 2009 – 
Niels Jørgen Olesen 
9:30 – 9:50 An update on the Infectious Salmon Anaemia (ISA) situation in Scotland  
– Eann Munro 
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9:50 – 10:10 Old and emerging diseases in Mediterranean aquaculture  – Giuseppe Bovo 
10:10 – 10:25 Detection of simultaneous multiple viral infection in a Swiss fish farm – Thomas 
Wahli 
10:25 – 10:50 Coffee Break  
10:50 – 11:10 Eradication of VHS from Denmark – surveillance and control – Henrik 
Korsholm 
11:10 -11:30 Pancreas disease (PD; an update on the disease situation and control measures in 
Norway - Torunn Taksdal 
11:30- 11:45 BKD - recent outbreaks in Norway - Hege Hellberg 
11:45-12:05 Red mark syndrome – a diagnostic challenge – Steven Feist 
12:05 - 12:20 Characterisation of a  Rosette Agent (Sphaerothecum destruens) from sunbleak 
(Leucaspius delineatus) in the UK – Richard Paley 
12:20 - 12:35 Biosecurity risks associated with EUS and Iridovirus in ornamental fish - 
Mansour El-Matbouli 
12:35 – 13:30 Lunch Break 
 
Thursday  27  
May - Annual Meeting of the National Reference Laboratories 
 
SESSION II: Technical issues related to sampling and diagnosis 
 Chair – Olga Haenen 
13.30-13.50 The new EU manuals on sampling and diagnostic procedures and the role of 
the www.CRL-fish.eu  web page - Niels Jørgen Olesen 
13.50-14.10 Diagnostic procedures for VHS, IHN, and EHN – Helle Frank Skall 
14.10-14.30 Molecular diagnostic procedures for KHV - conclusions and 
recommendations from EPIZONE workshop on KHV – Marc Engelsma 
14.30-14.50 Standard Diagnostic Procedures for ISA testing used at Marine Laboratory, 
Scotland – Eann Munro 
14.50-15.10 Diagnostic procedures for EUS – Birgit Oidtmann 
15.10-15.40 Coffee break 
15:40 – 16:00 Council Directive 2006/88/EC: The concept of un-explained increased 
mortality and how to deal with it from a legislative perspective – Sigrid Cabot 
16:00 – 16:20 Un-explained increased mortality in fish farming. A practical approach on 
how to deal with it. Experiences from Norway – Hege Hellberg 
16:20 – 16:40 Diagnostic sensitivity and specificity of test procedures for Renibacterium 
salmoninarum in rainbow trout - Malcolm Hall 
16:40 – 17:00 Non-lethal sampling and virus detection in fish latently infected with koi 
herpesvirus (KHV) – Sven M. Bergmann 
17:00 – 17:15 Cyprinid herpesvirus 3: To be, or not to be – Marc Engelsma 
17:15 – 17:30 A novel Real-time PCR assays detecting all VHSV genotypes – Søren Peter 
Jonstrup 
19:00 Banquet dinner 
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Friday 28 May  
Annual Meeting of the National Reference Laboratories  
 
SESSION III 
Scientific research update 
 Chair – Hege Hellberg 
9:00 – 9:20 Progress in the development of seroneutralisation test (SNT) for detection of 
Cyprinid herpesvirus 3 (CyHV3) antibodies in carp, Cyprinus carpio – 
Laurent Bigarré  
9:20 – 9:40 Vertical transmission - PD and ISA – Brit Hjeltnes 
9:40 – 10:00 Heart and Skeletal Muscle Inflamation (HSMI) – an emerging disease in 
salmon, new results indicating a reovirus – Irene Ørpetveit 
10:00 – 10:15 Club 5 project: Epizootic ulcerative syndrome. Development and 
implementation of diagnostic methods  – Olga Haenen 
10:15 – 10:35 Presentation of the Network of Animal Disease Infectiology and Research 
Facilities - NADIR – Torsten Boutrup 
10:35 – 10:55 Perch Rhabdovirus infection in farmed pike-perch and perch – an emerging 
disease - Laurent Bigarré 
10:55 – 11:15 microRNA regulation as a future diagnostic tool – Brian Dall Schyth 
11:15 – 11:35 Coffee break 
  
SESSION IV: Update from the CRL 
 Chair – Niels Jørgen Olesen 
11:35 – 11:50 CRL achievements in 2009 – Søren Kahns 
11:50 – 12:05 The Fish Pathogen Database – Søren Peter Jonstrup 
12:05 – 12:20 CRL workplan for 2010 – ideas and plans for 2011 - Niels Jørgen Olesen 
12:20 – 12:40 
 
Results and outcome of the Inter-Laboratory Proficiency Test 2009 – Søren 
Kahns 
12:40 – 13:00 Next meeting and end of 14th Annual Meeting - Niels Jørgen Olesen 
 Sandwiches and goodbyes 
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Workshop on Use of Diagnostic Kits for the Detection of Fish Diseases  
 
Use of diagnostic kits and reagents in the European NRLs 
Niels Jørgen Olesen and Nicole Nicolajsen 
DTU.VET. Aarhus, Denmark 
 
Abstract: 
This year the questionnaire on Surveillance and Diagnosis of fish diseases in Europe in 2009 
included a part requesting data on the use of commercial diagnostic kits in the respective NRL´s 
and regional laboratories. Based on the replies an overview of the use of kits in the NRL is given.  
For diagnosis of VHS and IHN, kits from the companies Bio-X and Test-line are used by a majority 
of the laboratories using commercial diagnostic kits. For KHV and partly ISA the marked is more 
spread. 
The presentation will in short describe available reagent and kits for detection of some of the listed 
fish diseases and their use in the NRL´s.   
 
Questions 
Athanasios Prapas: Is it possible to make revisions to the protocol of a kit to make it work in the 
laboratory? 
Niels Jørgen Olesen: Yes but alternative methods and reagents should always be tested and 
approved before use for diagnostic purpose. 
Olga Haenen: During validation you test for robustness, and within this a kit should work even 
though slight chances are made.  
Niels Jørgen Olesen: We encourage that users ask for documentation on how well the kit perform 
and how they were validated when you buy kits. The companies are not always presenting these 
data on their websites and it can therefore be hard to judge whether proper assessment of the tests 
has been performed. 
Alexandra Adams: We (Aquatic Diagnostics) send these reports to people who ask for them. 
 
Olga Haenen: From the questionnaire it cannot be derived how much people are using a specific 
kit and what their experience is. 
Niels Jørgen Olesen: This we can hopefully discuss at this meeting. 
 
Niels Jørgen Olesen: During proficiency tests many NRLs use commercial kits for identification 
of the pathogens and a lot of information from these tests are thus procured that companies might be 
able to benefit from in regards to providing information on how well their kit performs. 
 
Neil Ruane: Will this presentation be available at the CRL website? 
Niels Jørgen Olesen: Yes. (http://www.crl-fish.eu/Activities/survey_and_diagnosis.aspx) 
Neil Ruane: I would like to hear more about experiences from laboratories having compared 
different kits against each other. 
 
Giuseppe Bovo: There might be differences between batches of antibodies, kits etc. 
Niels Jørgen Olesen: Yes, we have also experienced this. We now always test new batches against 
old ones. 
Giuseppe Bovo: In the future we might ask which kits are used during the proficiency test? 
Niels Jørgen Olesen: Good idea.  
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Diagnostic tools: Development and validation of tests for detection of viral fish diseases  
N. J. Olesen1, S. Kahns1, S.P. Jonstrup1, H.F. Skall1 
1National Veterinary Institute, Technical University of Denmark  
 
Abstract: 
The range of diagnostic tools for viruses causing diseases in fish farming is as large as for virology 
in warm-blooded animals. Development of diagnostic tools has been based on empirical data and 
knowledge from general virological methods. Looking for differences it is obvious that especially 
temperature sensitivity always must be taken into consideration when examining for viruses from 
poikilothermic animals. A significant advantage of working with viruses from cold blooded animals 
is the relatively easy access and use of permanent cell cultures, these cells are often robust and easy 
to handle and often have virus susceptibilities that easily match the most sensitive molecular tests. 
Cell culture based techniques thus still have a significant position in fish virology both for 
diagnostics, surveillance and research. 
When developing a diagnostic test the first step is to determine the purpose of the test. Is it a tool 
for diagnosis of clinical cases, for justification of virus freedom, or for characterisation and use in 
e.g. molecular epidemiology? Demands for sensitivity and specificity highly depend on the answer 
to these questions, e.g. a test for diagnosis of disease in clinically sick fish demands a high 
specificity, whereas the sensitivity is of less importance. In contrast, for surveillance purposes in 
symptomless populations a high sensitivity is essential.  
 
After the development of the test it is a prerequisite that the test is validated before taken into 
general use. This has often been abandoned due to high work load, the cost of validation, the 
impossibility to fulfil all requirements e.g. due to lacking access to reagents, isolates etc.  
 
In 2004 an RT-PCR was recommended for detection of VHSV in the OIE Diagnostic Manual of 
Aquatic Animals. The procedure was included before a validation was finalised and it showed up 
that the recommended primers for VHSV may cross react with BF-2 cell fragments producing a 
fragment of a size similar to a VHSV fragment. Lacking knowledge of this phenomenon did 
contribute to the risk of false positive results. This may have grave consequences for the fish farm 
and the zone status. Due to this phenomenon a new RT-PCR has been included in the 2009 edition 
of the OIE manual. This new method has reduced the problem with false positives but did not 
eliminate them totally. Therefore continuous inclusion of the right controls is essential for the 
reliability of RT-PCR for VHSV detection, in this case non-infected or heterogonous infected cell 
culture material should act as negative controls. We are currently developing a real time PCR that is 
specific for VHSV. The validation of this technique include alignments with all published 
sequences and in-vitro testing against panels of more than 100 viruses representing all genotypes 
and various rhabdoviruses. In addition the test is validated against tissue material from infected and 
non infected fish of different species. Validation also include reproducibility, repeatability, 
efficiency and stability e.g. towards various kits, reagents etc. This validation resulted in a complete 
redesigning of the first candidate for a test, a test which already had passed intensive test regimes.  
Principles of validation of diagnostic test is described focusing on important steps like robustness, 
repeatability, analytical and diagnostic sensitivity and specificity and reproducibility with examples 
given from the current validation process of a real-time RT-PCR in our laboratory. 
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Questions 
Niels Jørgen Olesen: Unfortunately there is not much prestige in validation and it is hard to get the 
necessary funding for this work. Maybe there could be advantages in working together with other 
NRLs or companies? 
Hege Hellberg: Be careful about giving isolates etc. to companies. Later problems can arise where 
you are suddenly not allowed to use your own isolates. 
Niels Jørgen Olesen: Yes you might need assistance from a lawyer if you want to cooperate with 
companies in these ways. 
 
Giuseppe Bovo: It can be hard to find enough field material for validation. 
Niels Jørgen Olesen: It is correct, it is especially difficult to obtain enough A. invadans (EUS) and 
EHNV isolates. It could be a task for OIE reference laboratories to have a broad panel of isolates 
that can be send out to people who need to assess and  validate diagnostic tests.. 
 
Richard Paley: How often do you see unspecific bands in BF-2 cells of the VHSV PCR? 
Niels Jørgen Olesen: Quite often and other laboratories have also reported the problem. 
Richard Paley: We see it but only very seldom. 
Heike Schütze: You can use a digestion enzyme to discriminate between correct band and false 
positive bands. 
Søren Kahns: You may also sequence the product. We have done that but found no similar 
sequences in public databases. 
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Development and Validation of a Lateral Flow Kit to detect ISAV 
Alexandra Adams and Kim D Thompson 
Aquatic Diagnostics Ltd, Institute of Aquaculture, University of Stirling, Stirling, UK 
E mail: alexandra.adams@stir.ac.uk 
 
Abstract: 
Rapid diagnosis and immediate removal of infected fish are needed to implement effective control 
strategies during disease outbreaks. Lateral-flow immunoassays allow quick and sensitive detection 
of a pathogen, thus providing time to implement early control measures to avoid the spread of 
disease. This technology has many advantages over traditional immunoassays, in that the assay is 
simple to use, very rapid (with results in minutes rather than hours or days), low cost, and does not 
require skilled operators or expensive equipment. Evaluation of the results is performed by eye and 
total assay time is less than 15 min. In addition, the kits are stable at room temperature. These assets 
make the assay very suitable for on-site (or laboratory) sampling to detect pathogens.  
 
A Lateral Flow Kit to detect infectious salmon anaemia virus (ISAV) was developed using two 
ISAV-specific monoclonal antibodies. Initial kit validation for optimisation and standardisation of 
reagents, and assay repeatability and reproducibility, were performed in house. Kits were then sent 
out to independent laboratories in Scotland, Norway and Canada for validation with known positive 
and negative samples and clinical field samples to evaluate diagnostic sensitivity and specificity. 
Comparisons were made between the performance of the Lateral Flow Kit and other methods of 
ISAV detection, i.e. virus isolation, indirect fluorescence antibody test (IFAT), reverse transcriptase 
(RT-PCR) and real time quantitative reverse transcriptase (qRT-PCR). Laboratory trials were very 
effective, with the Lateral Flow Kit detecting ISAV in 100% of ISAV-infected samples with no 
cross reactivity with other pathogens. Field validation data was equally robust: correct diagnoses 
were obtained in 100% of clinical ISAV cases with the Lateral Flow Kits. No false positives were 
detected.  
 
The ISAV Lateral Flow Kit was shown to have the highest diagnostic specificity of all the methods 
used and a higher diagnostic sensitivity than IFAT. The method is easy and fast, and the kits are 
recommended for use on site to confirm clinical cases of ISAV. It would be useful to include this 
test in future ring testing for ISAV. 
 
Questions 
Alexandra Adams: Companies also see it as very important that their kits are probably validated. It 
does not give a good reputation if kits that do not function properly are being sold. 
Sven M. Bergmann: Is there a sterile immunity of ISAV or is there a latent infection? 
Eann Munro and Hege Hellberg: This is not known. 
Eann Munro: We demand 3 out of 3 PCR replicates to be positive for ISAV. It has been seen in a farm 
that 1 out of 3 was positive several weeks before an outbreak. 
Niels Jørgen Olesen: A fish farmer will be able to use your ISAV lateral flow kit, but will they 
report outbreaks? 
Alexandra Adams: The kit is designed for vets, but can of course be used by farmers, so this could 
be a problem as many farmers are not interested in knowing whether they have ISAV. 
Giuseppe Bovo: Do you sell mostly to farmers or vets and what is the price? 
Alexandra Adams:  We have sold only few because ISO-certification is not yet ready. Vets won’t 
buy until this is accomplished. Prices are around 10 pounds pr test. 
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Test-Line kits for the detection of fish pathogens 
Tomas Vesely 
 
Abstract: 
It has been reported that about a third of the economically valuable fish population die of some 
diseases every year. Diseases caused by viral agents significantly contribute to this situation. It is 
reflected in the EU legislation where four viral diseases are included in the list of non-exotic 
diseases. The OIE Code contains other three viral diseases of fish. 
A rapid and exact diagnostic procedure is very important for the detection of causative agents of the 
diseases. Application of ELISA tests based on reactions of specific antibody-enzyme conjugates 
and visualized substrate-chromogen reactions is one possibility. 
 
Regarding the nature of aquaculture in the Czech Republic and the epizootiological situation, three 
ELISA tests were developed in the early 1990s in collaboration between VRI and Test-Line 
diagnostics for detection of viral agents causing diseases of salmonid and cyprinid fish, namely for 
detection of infectious pancreatic necrosis virus (IPNV Ag ELISA), viral haemorrhagic septicaemia 
virus (VHSV Ag ELISA) and spring viraemia of carp virus (SVCV Ag ELISA). 
 
Principle of the tests 
Microtitre wells coated with specific antibodies to a virus are filled with tested samples, positive 
and negative control antigens. If present in the tested sample, viral antigens bind to antibodies. At 
the following incubation, rabbit antibodies to appropriate virus bind to the antigens. The binding of 
rabbit antibodies is detected in further incubation with conjugate solution (SwAR/IgGPx) and 
visualised by the reaction with substrate (TMB – Complete). After stopping the reaction by adding 
the Stopping solution, the colour intensity is measured using a photometer at 450 nm. 
 
This ELISA kits are suitable for the demonstration of mentioned viruses in organ homogenates as 
well as in infected cell cultures. The sensitivity of the methods (approximately 103 TCID50 per 0.1 
ml of the fluid examined) is satisfactory for routine examinations of field samples. Contamination 
with bacteria and fungi of samples taken from dead fish has no effect on the results of ELISA. 
Nevertheless, examination of fresh samples should be preferred. 
 
Questions: 
Neil Ruane: We have recently had problems with false IPN positives. It was due to the conjugate. 
Have others experienced problems? 
Eann Munro: We have also had problems. We contacted Test-Line however they never replied. In 
my opinion the suggested cut-off value is too low for this kit. 
Giuseppe Bovo: Is it possible to use the kits directly on fish samples? 
Tomas Vesely: The kits were originally developed to be used directly on fish, but the current EU 
legislation demands growth on cells first. 
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Development and assessment of reagents and diagnostic kits from  
BioX (Belgium) used in the NRL for Fish Diseases in Germany 
Sven M. Bergmann* and Dieter Fichtner 
Friedrich-Loeffler-Institut (FLI), Federal Research Institute for Animal Health, Südufer 10, 
17493 Greifswald-Insel Riems, Germany 
 
Abstract: 
The German reference laboratory for fish diseases (NRL-F), located on the Isle of Riems, uses and 
assesses commercially available kits and monoclonal antibodies (MAbs) from BioX, Belgium, 
detecting agents of notifiable diseases such as viral haemorrhagic septicaemia virus (VHSV) or 
infectious haematopoietic necrosis virus (IHNV), but also agents of not notifiable diseases such 
infectious pancreas haematopoietic virus (IPNV) or spring viraemia of carp virus (SVCV). 
Within the NRL-F mainly conjugated and non-conjugated MAbs recognizing IHNV, VHSV, IPNV 
and SVCV are used for indirect immunofluorescence assay (iFAT), respectively). The specificity, 
but also the feasibility of these MAbs is assessed with different virus isolates obtained from cell 
culture. For control reasons, different cell cultures, e.g. EPC, RTG-2, FHM or BF-2, are infected 
with different viruses for 1 – 2 days, then fixed with methanol-acetone (50:50, v/v) at -20°C and 
diluted MAbs are added for identification and differentiation as well as for detection of cross-
reactions with other perhaps similar viruses by IFAT. 
For detection of IHNV and VHSV an antigen ELISA kit (Duo kit) was tested for differentiation 
between these two viruses using cell culture replicated virus but also with infected tissue materials. 
Therefore a huge number of virus isolates isolated in different years are included in these tests. 
While very stable results are found by iIFAT and antigen ELISA for identification of VHSV, IHNV 
and IPNV, MAbs recognizing SVCV can cross-react with some other vesiculo-like viruses, e.g. 
Pike fry Rhabdovirus. 
 
 
*corresponding author: sven.bergmann@fli.bund.de 
 
 
Questions 
Olga Haenen: Did you ever isolate IPNV VR299 from eel? In The Netherlands this is found a few times in 
diseased eel. 
Sven M. Bergmann: No 
Niels Jørgen Olesen: Birnavirus 2 and IPN are both detected by BIO-X kit and therefore this kit is 
not specific for IPN. 
Niels Jørgen Olesen: VHSV detection limit of 105.5 TCID50/ml is quite high. 
Annita Ginter: Sensitivity could be made higher by using a 3 step ELISA instead of a 2 step. Tell 
us if you are interested in this and we can change it 
Niels Jørgen Olesen: Sensitivity is fine as long as detection is performed on cell culture amplified 
virus. 
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Specificity and sensitivity testing of commercial kits at the CRL  
 Helle Frank Skal, Ellen Ariel, Niels Jørgen Olesen 
 
Abstract 
When having CPE in cell culture it is for many laboratories convenient to buy a diagnostic kit to 
identify the cause of CPE. In order to avoid false positives and false negatives it is important that 
these kits are validated properly.  
At the CRL we are occasionally approached by commercial companies to help in this process.  
Some of these tests has already been published (Ariel & Olesen 2001) and resulted afterwards in 
improvement of one of the test kits. 
In 2002 the CRL was asked to test a VHSV ELISA kit from a commercial company and recently 
we tested the duo (VHSV and IHNV) ELISA kit from another company.  
 The panel of isolates used to test the VHSV ELISA kit lacked in genotype II and IV isolates. For 
the tested isolates of genotype I, Ia, Ib, Ic and III the kit detected all isolates, and IHNV, IPNV and 
SCVC was not detected by the kit. The kit performed equivalent to the CRL in-house ELISA in the 
tested samples. 
The analytical sensitivity was stated as 104 TCID50/ml by the producer. This could not be verified.  
Recently a duo ELISA KIT was tested against 78 VHSV isolates spanning all known genotypes and 
isolates from North America, Japan and Europe and 11 IHNV isolates. The kit detected all the 
tested VHSV and IHNV isolates with correct results. The kit generally produced lower OD values 
than the CRL in-house ELISA. The reason for this is probably caused by the set-up of the ELISA, 
as the commercial kit is a direct ELISA, whereas the CRL ELISA is indirect.  
The panel lacked of isolates other than VHSV and IHNV. 
The testing presented here are only very basic and lacks elements to be a proper validation 
 
References 
Ariel E. & Olesen N.J. (2001) Assessment of a commercial kit collection for diagnosis of the fish 
viruses: IHNV, IPNV, SVCV and VHSV. Bulletin of the European Association of Fish Pathologists 
21, 6-11. 
 
Questions: 
Athanasios Prapas: What was the sensitivity of the VHSV ELISA? 
Helle Frank Skall: Sensitivity was comparable to the sensitivity of the BioX kits described by 
Sven M Bergmann (104 – 105). 
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DNA-array based diagnostics: Applications in fish disease diagnosis 
Frans I.1,2, C. Heusdens1,2, K. A. Willems1,2, and B. Lievens1,2 
1Scientia Terrae Research Institute, Fortsesteenweg 30A, 2860 Sint-Katelijne-Waver, Belgium; 2Laboratory for 
Process Microbial Ecology and Bioinspirational Management (PME&BIM), Consortium for Industrial Microbiology 
and Biotechnology (CIMB), K.U.Leuven Association, Lessius University College, De Nayer Campus, J. De Nayerlaan 
5, 2860 Sint-Katelijne-Waver, Belgium. 
  
Abstract: 
The presence of fish pathogens represents a major concern in the international trade of ornamental 
fish, and fish disease management in general. Fish diseases can be caused by several organisms, e.g. 
bacteria, fungi, viruses and protozoa. Consequently, identification of potential pathogens requires a 
diversity of sometimes time-consuming and laborious assays. The advent of molecular biology, in 
particular polymerase chain reaction (PCR), has lead to alternative means for pathogen detection 
and identification. Nevertheless, although most of these methods are suitable for the detection of a 
single pathogen, they are not convenient to simultaneously detect a whole range of pathogens. In 
contrast, PCR-based DNA array technology allows detection and identification of numerous targets 
in a single assay. Based on this technology, a diagnostic assay has been developed for the detection 
and identification of approximately 30 fish pathogenic bacteria and viruses. Each diagnosis can be 
achieved within 36 hours based on an objective technique utilizing an array of immobilized 
pathogen-specific DNA fragments. Recently, the assay has been adopted by routine diagnostic 
laboratories providing diagnostic services to veterinarians, whole sealers, inspection agencies etc. 
Results illustrating the development and power of the assay for accurate and efficient diagnosis of 
fish diseases will be discussed in the presentation. 
 
Questions: 
Marc Engelma: You have 3 independent assays now? 
Ingeborg Frans: Yes, but we work on combining them to a single assay. 
Sven M. Bergmann: What is the sensitivity for detection of KHV? 
Ingeborg Frans: A few picogram of input material is needed. 
Heike Schütze: Which genes for KHV do you amplify? 
Ingeborg Frans: Three genes: Thymidine kinase and two others 
Richard Paley: What is the cost to run the assay? 
Ingeborg Frans: 175 euro pr. array 
Niels Jørgen Olesen: Do you look at regulation of host gene expression involved in immune 
response? 
Ingeborg Frans: We have been looking at it but there is still a lot of work to do. 
Olga Haenen: Which organs do you sample? 
Ingeborg Frans: It depends on the pathogen we want to detect. 
Malcolm Hall: Cross contamination can be a problem in relation to PCR based diagnostic. Have 
you experienced contamination problems? 
Ingeborg Frans: We work in different rooms for different processes and use several controls. 
Malcolm Hall: Could be a problem if other labs should work with this. 
Svenn M. Bergmann: Is it possible to examine pools of fish? 
Ingeborg Frans: We have pooled a few fish but we have not made extensive studies on this. 
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Experiences with the use of LAMP originated kits in KHV diagnostics in comparison to other 
tools 
Sven M. Bergmann* 
Friedrich-Loeffler-Institut (FLI), German Reference Laboratory for KHVD, Federal Research Institute for Animal 
Health, Südufer 10, 
17493 Greifswald-Insel Riems, Germany 
 
Abstract: 
 
Koi herpesvirus disease (KHVD) has spread world-wide obviously by transfer of infected but non-
diseased koi and / or common carp (Cyprinus carpio). Due to the limited sensitivity of the available 
cell cultures, e.g. common carp brain cells (CCB) or koi fin cells (KF-1), for virus isolation, 
molecular tools are in the focus as “gold standard” for KHV detection. Beside different molecular 
assays such as PCR, nested PCR, real-time PCR or even in-situ hybridization on tissue material, a 
new method was established. This method, called “loop-mediated isothermal amplification 
(LAMP)” of DNA, possesses the advantage of amplification at one temperature. No PCR 
equipment or PCR protocols are necessary. 
In the German reference laboratory for KHVD (NRL KHVD) different LAMPs were tested and 
compared for specificity and sensitivity and compared to other recently used assays. 
Additionally, the NRL KHVD supervised a LAMP development which was the subject of a 
diploma thesis. All these experiences were incorporated into the assessment of tests for detection 
and differentiation of KHV. 
While all tested kits were specific to DNA obtained from KHV infected materials (infected cell 
cultures, infected fish tissues), the sensitivity did not reach that of PCR or real-time PCR. While 
LAMPs for agent identification are useful when KHV is present in huge concentrations in or on 
infected fish during an outbreak of KHVD, as one of our results we could show that LAMP and its 
commercial variants, e.g. “loopamp” from Eiken Corp. (Japan) or the “i-screen KHV kit” Gene 
Reach Biotechnolgy Corp. (Taiwan) but also the newly developed LAMP, were never able to 
identify low KHV concentrations from tissue or droppings of latently (persistently) infected fish.  
Some data sheets indicate that a negative result of the LAMP assay might by due to latency. 
According to our observations, a LAMP will give positive results only at KHV concentrations of 
more than 104 / 105 genomic copies / ml, comparatively measured by real-time PCR.  
A new, much more successful LAMP simultaneously using anti-KHV serum from rabbit for virus 
attachment in tubes was published in 2009. Due to virus attachment to the tubes, the test sensitivity 
was increased considerably. 
*corresponding author: sven.bergmann@fli.bund.de 
 
Questions 
Marc Engelsma: I have tried I-screen as well but never got any positive spots. 
Sven M. Bergmann: You have to use very high concentrations to get a positive result 
Søren Kahns: Can everybody use this kit test or is it only experienced laboratory personnel? 
Sven Bergmann: In principle, everyone can perform the test. 
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Plenum discussion: 
Giuseppe Bovo: Are we as NRLs obligated to test all the kits the different laboratories in our 
country uses?  
Niels Jørgen Olesen: No, but by providing proficiency tests you ensure that laboratories can detect 
relevant diseases. 
Sven M. Bergmann: In Germany companies have to pay for testing and approval of their kits at the 
NRL. 
Richard Paley: It would be nice to be informed on experiences made by other laboratories. Could 
we add validation reports to the CRL-website? 
Niels Jørgen Olesen: Yes, but it will be hard to ensure quality of the reports. 
Sven M. Bergmann: The reports are often owned by the companies who pay for them. 
Annita Ginter: We are open about our reports at Bio-X but of course it varies depending on the 
report in question. 
Niels Jørgen Olesen: Maybe there should be golden standards to test different kits against?  
Neil Ruane: The availability of a range of ‘Golden standards’ would be a powerful tool for the 
validation of diagnostic kits and method development within the NRL network. 
Annita Ginter: Often the companies need to do a lot of work for getting our products approved in 
the different member states. 
Niels Jørgen Olesen: Are people satisfied with the tests available? 
Athanasios Prapas: Kits for the new listed diseases could be nice. 
Olga Haenen: It is hard to validate tests where you only have very few samples. 
Niels Jørgen Olesen: Maybe in some cases it could be beneficial to license diagnosis of certain 
diseases to other laboratories receiving more samples. 
Niels Jørgen Olesen: It could pose a problem that kits are becoming available for fish farmers that 
thereby can monitor themselves. They might not report listed diseases. The fish farmer will not 
validate his procedure. 
Niels Jørgen Olesen: One of the conclusions must be that it is necessary to validate kits in the 
respective laboratory before use and also to ask companies for documentation of the validation 
performed when a new kit is to be used. 
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SESSION I: Update on important fish diseases in Europe and their control 
 
Brit Hjeltnes: If you don’t know the situation you can’t do anything about it, so this session is 
important.  
 
Overview of the disease situation and surveillance in Europe in 2009  
N. J. Olesen and N. Nicolajsen 
National Veterinary Institute, Technical University of Denmark  
 
Abstract: 
The Questionnaire on Surveillance and Diagnosis (S&D) which is collated annually is the only 
comprehensive overview of the disease situation in aquaculture in Europe. The information has 
been made available on the CRL web site (www.crl-fish.eu), where all raw data can be obtained. 
The S&D have evolved over the years to now comprise 4 parts: General data on production, 
epidemiological data on diseases, laboratory data from NRLs and other laboratories, and 
categorisation of fish farms according to Council directive 2006/88/EC. As we are collating 
information on quality assurance in NRLs through the annual proficiency test this part of the 
questionnaire 2009 was omitted. The data on the European aquaculture production were obtained 
from the FIGIS database. Unfortunately this database does not include information on the number 
and size of fish farms, which are epidemiologically important data. The production in 2008 has 
risen a bit again after a decrease from 2003-2006. Data from 2009 is not yet available. The farm 
sizes vary a lot between countries, e.g. the majority of farms in Germany produced < 5 tonnes, and 
for Spain the number of farms producing < 5 tonnes, 5-100 tonnes and > 100 tonnes is nearly equal.  
In Northern European countries there are mainly salmonid farms, in continental Europe we find a 
lot of carp farms, and in the Mediterranean area, besides carps, seabream and seabass are also 
species that many produce. Turkey is a big producer of rainbow trout and lots of rainbow trout 
farms is found in this country.  
Concerning the epidemiological data, there obviously still is a severe underreporting of VHS and 
IHN in many countries. The infection status is known for about ½ of the farms. 
The infection status regarding KHV is unknown for many carp farms, whereas for farms producing 
Atlantic salmon, the infection status for ISA is known for nearly all farms. ISA is still a problem in 
Norway.  
Many countries have surveillance programmes for SVC, BKD, and IPN, for which they are seeking 
“additional guaranties”. The number of farms in the programmes varies from very few farms to 
many farms. Fewer countries have surveillance programmes for Gyrodactylus salaris.  
There is very large differences between countries on how many samples are tested on cell cultures, 
ranging from < 100 to several thousands. PCR is coming up in many countries, but the large 
number of PCR-tests conducted in some countries mostly reflects the KHV and ISA testing.  
About a third of the countries have regional laboratories, and of these countries, 8 of 11 organize 
ring tests for the regional laboratories.  
A total overview of the current status of the categorisation of fish farms in Europe will be given. 
 
Minutes: 
Due to the sheer volume, all the results from the Survey & Diagnosis questionnaire have not been 
inserted in the Annual Meeting booklet this year. Instead all the results will be published on the 
CRL website (http://www.crl-fish.eu). This presentation will also be available on the CRL website.  
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An important duty for the CRL is to collate information on the disease status in Europe. 
The questionnaire has been divided into different chapters: General data, epidemiologic data, 
laboratory data, proficiency tests offered to regional labs and a final chapter on the use of kits in the 
NRLs.  
General data: We ask for number of farms according to production size. The production of 
freshwater fish in Europe has been steady during the last 10 years. This is worrying when compared 
with the rise in the worldwide production. The marine fish production has risen a bit during the last 
10 years.  
The distribution of farms according to size varies a lot between the countries. E.g. Germany has 
mainly small farms, whereas Scotland mainly has large farms. Likewise does the species farmed 
vary a lot between the different countries.  
Health categorisation: For VHS over half of the authorised farms in Europe are in category III and 
the remaining in category I or II. The picture looks the same for IHN. There is still a lot of 
underreporting of VHS and IHN. For KHV most carp farms are in category III, unknown status. A 
lot of farms are not categorised yet. However, categorisation is in good process when comparing to 
e.g. the molluscs farms in Europe. There are several different views on how categorisation shall be 
performed.  
Epidemiological data: We asked the laboratories to state the number of farms considered to be 
infected to get a “real” picture, and not just the official picture. For VHS and IHN, we know the 
exact status for 1/3 of the farms, whereas for KHV we don’t know the status for most of the farms. 
There does not seem to be any real emerging diseases in 2009. For the Mediterranean area 
nodavirus seems to appear a lot. There was an increase of ISA in Scotland and a decrease of VHS in 
Denmark with no infected farms. In Austria there was a decrease in the severity of KHV.  
Laboratory data: Some countries are doing a lot of examinations. PCR is really coming up as a 
diagnostic tool.  
 
Questions: 
Mansour El-Matbouli: What is your interpretation that most farms are placed in category III, is it 
good or of concern? 
Niels Jørgen Olesen: It was newer the idea the cat. III should be the final stage. When a fish farm 
is in cat. III there is an obligation to survey actively in order to move on.  
Sigrid Cabot: I have one comment to categorisation. Some farms which in this overview are put 
under cat. II, are according to the EU legislation in cat. IV. When a surveillance programme is 
established with the aim to obtain disease freedom, it is important to declare the programme to the 
European and the other Member States through SCFCAH.  
Niels Jørgen Olesen: I think the intention of cat. IV and II has not been followed, most are put in II 
instead of IV. 
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An update on the Infectious Salmon Anaemia (ISA) situation in Scotland 
Eann Munro 
Marine Scotland Science, Marine Laboratory, 375 Victoria Road, Aberdeen, Scotland 
 
Abstract: 
Infectious salmon anaemia (ISA) is a multisystemic contagious disease of farmed Atlantic salmon 
(Salmo salar L.) caused by the orthomyxovirus, infectious salmon anaemia virus (ISAV). The 
disease is characterised by severe anaemia and haemorrhaging in several organs. Disease outbreaks 
are predominately associated with Atlantic salmon farmed in the marine environment. A previous 
ISA epizootic was detected in Scotland in 1998 when the disease spread from a single source of 
infection. Through implementation of an effective eradication programme this epizootic was 
eradicated and ISA disease freedom regained. In January 2009 the presence of ISAV was detected 
within a population of farmed Atlantic salmon in the South West Mainland of the Shetland Islands. 
In total, 6 sites all of which were in close geographical location to each other were confirmed as 
ISAV positive. 
In accordance with EU Council Directive 2006/88 and commission decision 2003/466 control 
measures were implemented once suspicion of ISA was placed on the initial site. Notices were 
served, prohibiting the movement of live and dead fish, personnel, vehicles, equipment, materials or 
substances that could potentially transmit infection on or off the farm. Control and surveillance 
zones around the infected sites were also established which placed restrictions on all farms within 
these areas. All sites within these zones and sites which had significant epidemiological links to the 
infected sites were inspected and screened for ISAV. A wild fish survey of the surrounding marine 
and freshwater environments produced negative results. 
Scottish Government policy is to eradicate ISA through removal of infected stocks.  The speed at 
which the removal is required takes account of the risk of spread and in the 2009 outbreak the 
scientific advice was for rapid removal of all fish from ISA confirmed sites. Depopulation of all 
confirmed sites was achieved within a 7 week period from the date of official confirmation. Once 
the depopulation and disinfection processes were performed, confirmed sites remained fallow for a 
minimum of 6 months and all sites within the control zone had to be synchronously fallowed for a 
minimum period of 6 weeks. Sites within the surveillance zone were required to undergo an 
asynchronous fallow of 6 weeks.  The Atlantic salmon aquaculture facilities within the control zone 
began restocking in March 2010.  
A 2 year targeted surveillance programme within the South West Shetland Islands, to demonstrate 
negative results for ISA which would enable the lifting of control measures such that the whole of 
the UK can be an approved zone for ISA in accordance with Council Directive 2006/88/EC will 
begin in May 2010.  
To conclude, 6 sites were confirmed ISA positive from January to November 2009. All sites were 
located in the South West Shetland Islands; within the one control zone. There is no evidence of 
ISAV spread out with this control zone and the disease has been eradicated from the South West 
Shetland Islands. Inspections and testing of the restocked farms within this area will begin in May 
2010 to regain ISA disease free status within this area. 
 
Minutes: 
Rob Raynard gave a presentation on the ISA outbreak last year. This will be an update to this 
presentation. 
ISA is a multisystem disease of Atlantic salmon worldwide caused by an orthomyxovirus. The ISA 
virus is of 2 independent origins, one in Europe and one in North America.  
EU legislation to take into account: CD 2006/88/EC and CD 2003/466/EC 
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In Scotland we have experienced two outbreaks: 
1) May 1998 - May 1999: 11 cases and 2) the 2009 outbreak: The outbreak occurred on the 
Shetland Isles. This has been very grave for the industry as the Shetland Isles produce 10% of the 
Atlantic salmon production. The outbreak was notified by a phone call due to high mortality at a 
fish farm. At visit by the veterinary officers there were clear ISA symptoms. A containment area 
was established January 2009. Monthly inspections in control zone occurred every 2 months in the 
surveillance zone. Targeted surveillance (150 fish) in the control zone from each farm. Various 
assays were used for confirmatory diagnosis. The different farms had big variations in mortality.  
The Scottish Government policy is to eradicate the disease. All sites were depopulated within 7 
weeks. When a site is confirmed positive it is cleaned and disinfected and fallowed for a minimum 
period of 6 months. All associated equipment and boats are also cleaned and disinfected. Sites 
within the confirmed area which were not tested positive were fallowed for 6 weeks. Wild fish 
testing of 216 freshwater and 1196 marine fish by PCR was performed with negative results.  
ISAV in Shetland (2009) differed to the isolate causing the outbreak in Scotland 1998, neither was 
it similar to Scottish HPR0 (avirulent). Originated from either an import or from a mutation of other 
HRP0s in the environment.  
The epizootic investigation will be published on the marinescotland website within the next few 
months.  
Likely source and spread: The source is at present unknown, the isolate has a novel HRP type. The 
spread of the disease seems to be hydrodynamic. 
To date 7 sites within the control zone have restocked, the first one restocked in March.  
In all 6 sites were confirmed positive during the outbreak.  
 
Questions: 
Steve Feist: How did you decide the extent of the zones? 
Eann Munro: The extents of the zones were based on tidal excursion models developed during the 
last outbreak. The models cover the whole of Scotland. 
Niels Jørgen Olesen: When you are surveying you use qPCR assays – what will you do if you find 
HPR0? 
Eann Munro: A positive PCR result will only result in suspicion, in addition we always perform 
sequence analysis on PCR positive samples and we also analyse the results of other assays. Once 
suspicion is raised we will go back to the site and examine 150 fish and if negative after additional 
sampling then the farm is deemed ISA negative.   
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Old and emerging diseases in the Mediterranean Aquaculture 
Bovo G. 
Istituto Zooprofilattico Sperimentale delleVenezie 
Viale dell’Università, 10, 35020 Legnaro –PD 
E-mail: gbovo@izsvenezie.it 
 
Abstract: Beside the traditional trout farming existing in some Mediterranean countries, as an 
industrial activity, since mid-twentieth century, the younger seawater fish farming, consolidated 
since 1980s, has now reached significant productions. In fact, according to the Federation of 
European Aquaculture Producers (FEAP) more than 290 thousand tons of seabass and seabream, 
which represent the most important species, have been produced during 2008. Local pathogens, 
already present in the wild populations and exotic pathogens introduced through the trade, appeared 
very soon in farmed population. Nowadays old and emerging diseases play an important role with 
regard the health of both juveniles and on-growing farmed populations, often representing a 
limiting factor to the production. 
In order to obtain updated information on the most serious diseases affecting the aquaculture 
industry in the Mediterranean area a questionnaire was sent to 12 fish-pathology experts. 11 reports 
were obtained back and in five questionnaires data on salmonid diseases were also included. 
According to the questionnaire old, emerging and re-emerging diseases were reported at Country 
level as well as their endemic or sporadic status. In addition the control methods applied were 
included for each disease.  
The trout industry is still threatened by serious viral diseases as infectious pancreatic necrosis (IPN) 
and viral haemorrhagic septicaemia, particularly in mountain areas characterized by low water 
temperature. In other regions where farms are fed with higher water temperatures (14-15°C) viral 
diseases are less frequent and outbreaks less severe. In these areas bacterial diseases represent the 
most serious risks, particularly during summer. Infections induced by Flavobacterium  
psychrophilum seem to be widespread in several Countries and difficult to eradicate even in 
hatcheries where losses may reach more than 50% if no adequate therapy is immediately 
established. No vaccine is available yet.  
The infection due to Lactococcus garvieae is endemic in some regions and in hot seasons 
particularly in association with water scarcity losses may exceed 50%, particularly in market size 
fish. Antibiotic therapy is not effective mainly because of the early appearance of anorexia.  In 
some Countries a vaccine, produced from inactivated cells is available but complete control of the 
disease is difficult to obtain because of the limited protective period. 
Concerning marine aquaculture, viral encephalopathy and retinopathy (VER) remains one of the 
most serious problems mainly in seabass farms where losses may vary from 5 to 100 % depending 
on the age of the affected population. More recently VER outbreaks have been observed in 
seabream affecting larval and juvenile stages. Furthermore new candidate aquaculture species like 
Solea senegalensis have been seriously affected. During summer 2009 VER was diagnosed in a 
farm rearing pike-perch (Sander lucioperca) and largemouth bass (Micropterus salmoides) in 
freshwater environment. This new finding underlines the large host spectrum of betanodaviruses 
and new additional species could be affected in the future for this reason attention should be paid to 
avoid contact with known and unknown susceptible species. 
Among emerging diseases reference should be made to furuncolosis and IPN infection detected in 
sole. The major emerging problem is represented by rash skin syndrome a pathological condition 
endemic in the Mediterranean Iberian coast and affecting only sea bream. Mortality is very low but 
affected fish, characterized by the presence of evident ulcers in the skin may not be traded until the 
complete recover of the clinical signs.   
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Minutes: 
A questionnaire was sent out to several experts working on different Countries in the Mediterranean 
aquaculture. 
The production is mainly represented by bream, bass and different trout species but also turbot, 
tuna, meagre, sturgeon and eel are produced.  
Salmonids and related pathogens: In the questionnaire sent out I asked for 2-3 most important 
diseases: The situation may differ a lot according to where the farm is situated in a country. E.g. 
VHS in Italy: A farm placed in the mountainous area are in a much greater risk of disease outbreaks 
due to VHS than farms placed in the lowlands due to the different water temperatures. Rainbow 
trout fry syndrome (RTFS) is one of the most important diseases; VHS, IPN and Aeromonas 
salmonicida are also very important. RTFS is reported from Spain, Turkey and Italy. Lactococcus 
was only reported as an important disease from Italy. This means that the disease may be easily 
controlled in other areas, possibly by means of vaccination. From Greece we received reports of 
HVA in eels, while from Italy VER was reported once in freshwater fish. 
In the marine environment the major problem is still represented by VER (age depending, sporadic, 
emerging, problem in Spain, Greece, Turkey, Italy); rash skin syndrome, which is very similar to 
red mark syndrome of rainbow trout, with fish showing  skin lesion, disappearing when temperature 
increase at >17°C. Fish may be advantageously treated with oxytetracycline, maybe correlated to 
clamydia infection, only seabream is affected; pasteurellosis (reported from Greece, Tunisia and 
Turkey), Cryptocarion infection, vibriosis, furunculosis, isopods (reported from Greece and 
Croatia), protozoans, gill trematodes (reported from Greece and Italy). VHS has been reported from 
turbot in Turkey.   
A question is if we should expect further problems due to tuna farming? Frozen fish from all over 
the world are used for feeding and that may introduce pathogens that are not present in the 
Mediterranean area.  
 
Questions: 
François Lieffrig: You have seen VNN in freshwater?  
Giuseppe Bovo: Yes, it started in fry imported from third country.  
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Detection of simultaneous multiple viral infection in a Swiss fish farm 
Thomas Wahli 
Centre for Fish and Wildlife Health, Institute of Animal Pathology, University of Bern, 3001 Bern 
 
Abstract: 
A fish farm in Southern Switzerland experienced increasing mortalities of rainbow trout in early 
spring 2010. The events started after increased quantities of snow melting water from an adjacent 
road flowed into the ponds of the farm. This was firstly considered as the reason for the losses. In 
the respective facility bacterial gill disease, rainbow trout fry syndrome and the virus of pancreas 
necrosis had been demonstrated repeatedly in previous years, bacterial gill disease also early in 
2010. As mortalities went on, a new lot of fish of the most affected lot was analysed. Besides a 
marked gill proliferation (no bacteria could be demonstrated but the fish had been disinfected 
before analysis) IPN could be diagnosed. The viral infection however was not regarded as cause for 
the increased mortality as the fish measured up to 13 cm. Fish not showing any disease signs nor 
mortality were transferred to a second farm of the same owner in order to separate them from 
diseased fish. Despite further disinfections the situation in the first farm did not improve and 
therefore fish from different ponds, size and age classes were analysed 10 days later. On this 
occasion, in one sample viral haemorrhagic septicaemia was diagnosed, while fish from a second 
lot were infected with birnavirus. Trout from a third lot showed neither mortality nor disease 
symptoms and no virus could be detected. As a consequence fish from 9 tanks from both farms 
were subjected to virology. In some of the fish few disease symptoms such as pale gills, watery 
intestinal content, greyish liver was seen but the majority of fish presented without any macroscopic 
symptoms. Nevertheless VHSV was found in 4 samples. In one sample besides VHSV also IPNV 
was found. In addition, in two samples infectious haematopoietic necrosis virus (IHNV) was found, 
among them one where also VHSV had been demonstrated. The results were confirmed by RT-
PCR. Thereby in further samples double or even triple infections were detected. Both farms 
harboured virus-infected fish. Both farms were sequestered and sanitation measures were initiated 
including stamping out of all stocks.  
The results showed that detection of one virus species in cell culture can at least partly be 
influenced by the growth of another virus present in the same fish. 
 
Minutes: 
This is a report of a case of multiple infections that we have had for the first time in Switzerland. 
The case concerns two fish farms belonging to the same owner in the south of Switzerland. Both 
farms are fed of river water but not of the same river and the production is organic rainbow trout. In 
farm A there were regular infections with bacterial gill disease, RTFS and in farm IPNV. Farm B 
was restarted recently after a fallowing period of several years due to a bacterial disease. 
In January elevated mortality was observed in farm A. RTFS was diagnosed. In February high 
mortality was observed after massive inflow of melt water from a nearby road. Diagnosis: 
proliferation of gill epithelium, protozoan infection of intestines. Transfer of fish to farm B, where 
no problems with snow water occur. In March: Ongoing mortality, new samples were taken. IPNV 
was in sample 1, in sample 2 was VHSV. This raised the questions: How widespread is VHSV in 
the facility? Is the demonstration of VHSV hampered by presence of IPNV? In Switzerland IPN is a 
notifiable disease so we do not use anti-IPNV antibodies in cell culture. Was VHSV present earlier? 
Further investigations: Farm A: 3 samples negative for viral growth, 2 samples positive for VHSV, 
1 sample positive for VHSV and IPNV. Only very mild macroscopic symptoms were observed. 
Farm B: 1 sample negative for viral growth, 1 sample positive for VHSV, 1 sample positive for 
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IHNV, 1 sample double infected with IHNV and VHSV. Macroscopic symptoms in fish were 
observed only in one sample. By PCR IHN was also found in farm A.So in fact there were triple 
infections. 
Conclusion: When taking together cell culture results and RT-PCR analyses, we identified double 
infections in 3 cases, triple infections in 2 cases. In case of growth of IPNV, infection with either 
VHSV or IHNV is not necessarily detected in cell culture. The origin of virus is not yet determined. 
Investigation of stock movement in the last several months is needed. Further investigations of wild 
population in the rivers should be performed. In both farms stamping out of all stocks followed by 
sanitation has been performed. There is now a discussion on application of detection methods.  
 
Questions:  
Torunn Taksdal: Are there triple or double infections in one single fish? 
Thomas Wahli: The samples were made from a pool of 3-5 fish from one particular tank. 
 
 
Final eradication of VHS in Denmark? Categorisation of and risk based surveillance on Danish 
fish farms. 
H. Korsholm. 
Danish Veterinary and Food Administration, Tysklandsvej 7, 7100 Vejle, Denmark. HKO@fvst.dk 
 
Abstract:  
The preliminary results of the Danish programme for a final eradication of VHS in the period of 
2009 -2013 are presented. There have been no outbreaks of VHS since the start of the project (April 
1st 2009). The disease preventing measures (main fallowing, auxiliary fallowing and removal of 
wild living rainbow trout in high risk watercourses) have been carried out as scheduled. Reflections 
on the categorisation of and the risk based surveillance and testing on Danish fish farms are 
presented. It is concluded that Danish fish farms are at high to medium risk and that targeted 
surveillance will be continued. 
 
Minutes: 
History of VHS in Denmark: 1950s: First observation of VHS. 1960s: Private voluntary 
eradication. 1970: Official control of VHS eradication. 2009: Final eradication of VHS? 
Programme for final eradication 2009-2013: The industry delivered Denmark free of VHS infected 
fish by 1 April 2009. Application for an eradication programme was sent to EU May 2008 and 
approved autumn 2008. The eradication programme is financed by a European Fisheries Fund 
grant. 
Preventative measures 2009-2010: Main fallowing of 7 brackish water farms from 1 April 2009 - 16 
May 2011. Auxiliary fallowing of 19 (2009)/13 (2010) fresh water farms 1 April – 16 May same 
year 
Removal of wild living rainbow trout in high risk water courses by electro fishing (2009 and 2010). 
The fish were examined for VHSV with negative results.  
Structure of VHS eradication programme: In case of VHS outbreak it is mandatory with immediate 
stamping out. There is taxation and compensation for the value of the fish. 
Advantages for the programme: Favourable epidemic situation. Declared wish form the industry. 
Financial support. Preventative measures. Immediate eradication is mandatory. 
Disadvantages: Limited possibilities for official eradication. Risk of re-infection from anadromous 
fish 
Project runs to 2013 only. What do we do with the sea farms? We will like to block the transfer of 
marine fish into the freshwater environment.  
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Categorisation with respect to VHS: Cat I zone: 186 farms. Cat I compartment: 45 farms. Cat II: 66 
farms. Cat III: the sea water farms. 
Risk based surveillance: Are the farms situated far away or close to infected areas? Far away - low 
risk  
Cat. I compartment within infected area – high risk. In between – medium risk. Marine: high risk 
Type of health surveillance: active, targeted 
At the moment all farms in DK are high to medium risk with targeted surveillance 
 
Questions: 
Giuseppe Bovo: Will all controls in Denmark be performed by the competent authorities? 
Henrik Korsholm: Yes. 
Giuseppe Bovo: And the farmers don’t pay? 
Henrik Korsholm: Yes and no, until now they have been sustained, but this may change in the 
future. 
Thomas Wahli: What are the measures taken in the sea water farms? 
Henrik Korsholm: We will act the same way disregarding which genotype a marine farm is 
infected with. VHSV is VHSV no matter what. 
 
 
Pancreas disease (PD); an update on the disease situation and control measures in Norway 
Torunn Taksdal 
National Veterinary Institute, Norway 
 
Abstract:  
 
Pancreas disease (PD) and Sleeping disease (SD) are serious viral disease which are caused by 
Salmonid alphavirus (SAV). Until now, PD outbreaks are restricted to farmed salmonid fishes in 
sea water. In Scotland and Ireland, PD affects only Atlantic salmon in sea water whereas in 
Norway, both Atlantic salmon and rainbow trout in sea water suffer from PD. In several European 
countries, SD affects farmed rainbow trout in freshwater.  
 
In western Norway, serious outbreaks of PD have been diagnosed yearly since 1995. The affected 
area has expanded north- and southwards from this “hotspot”. Some outbreaks far north from the 
endemic zone have been connected to transportation of fish from the endemic zone. The number of 
outbreaks increased until 2008 when 108 outbreaks were recorded. In 2009, the number of outbreak 
was reduced to75.  
 
From December 2007, PD was included as a “group B” listed disease in Norway. Preventive 
measures have been established by the Norwegian Food Safety Authority. The main aims are to 
prevent further spread from the endemic zone to the non-endemic zone and to reduce the negative 
impact of the outbreaks inside the endemic zone. More precisely; Norway has now been divided 
into two zones. In the north, non-endemic zone, the preventive strategy implied from Norwegian 
Food Safety Authority, is stamping out, whereas inside the endemic zone, the aim is to reduce the 
negative impact of the disease. This work goes along with important industry initiatives against PD, 
targeting the same aims. This includes vaccination against SAV, grouping of fish farms giving “fire 
gates” as well as other hygienic measures. However, the structure of the industry, with several boats 
still travelling among the fish farms, to and from slaughter houses and even between different 
countries, still represents a significant risk of spreading the virus and the disease.  
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Minutes 
PD and SD are similar diseases caused by salmonid alphaviruses.  
SAV subtype 1, 4, 5 and 6 have caused PD in Atlantic salmon in Ireland and Scotland. SAV2 have 
caused sleeping disease in rainbow trout in fresh water in several European countries. SAV3 is 
found in Norway. 
Lesions: loss of exocrine pancreatic tissue. After an outbreak you see thin PD-runt compared to a 
healthy fish. They are starving although they eat a lot. 
PD is a severe disease in Ireland, Scotland and Norway. Tri-nation cooperation on PD and similar 
diseases has been established among these countries. The number of PD-outbeaks in Norway has 
been low from 1998 to 2002, when it started to raise and reached a high levels at the end of the 
decade (2007, 2008).  
Is there SAV subtype 3 infections in fresh water? Freshwater farms were sampled before the fish 
were released to seawater. No virus was found. The smolts were followed in the seawater at 51 
seawater sites. There is a PD-zone where a lot of farms are infected. North of this zone neither SAV 
nor PD was detected on 15 sites. South of the zone PD is not detected either.  Evaluation of risk 
factors inside the PD zone: No significant difference between sites with and without PD/SAV inside 
the endemic zone. The infection pressure within the affected area was probably the dominant risk 
factor.  
Is SAV a persistent infection? 14 sites were followed by sampling after first detection. All 14 sited 
tested positive for SAV at subsequent samplings.  
Clinically healthy fish may harbour SAV. Registered time between infection and disease has been 
up to 18-37 weeks. PD diseased fish have been detected up to 12 months after first diagnosis. 
Control strategies: Prevent further spread to new areas. PD is a list 3 disease in Norway since 2007. 
The industry has control strategies against PD. North of the zone stamping out are used in 
cooperation with the industry. Last outbreak north of zone was in August 2009. Inside the zone 
there is mitigation. Information, hygienic measures, vaccination (no control group to validate the 
vaccine as nearly all are vaccinated), grouping of sites and fire gates, coordinated fallowing, safe 
transport routes are some of the measures used.  
The PD situation in Norway is still serious. The structure of the industry include a lot of boat traffic 
between fish farms, equipments etc. There have been rumours that such boats also goes to North 
America and back.  
 
Questions: 
Athanasios Prapas: Regarding the vaccine, you are not able to validate the vaccine? 
Torunn Taksdal: There have been good results in experiments, but the real challenge is in the 
field. We have identified PD-diagnosed fish that have been vaccinated. 
Niels Jørgen Olesen: Are the PD-viruses all the same for the different outbreaks. Does the vaccine 
preferably protect against certain forms of the virus? 
Torunn Taksdal: There are very few differences in the virus.  
Brit Hjeltnes: As far as I know, the lack of efficacy does not correlate to the virus strain. 
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BKD – recent outbreaks in Norway 
Hege Hellberg and Hanne K. Nilsen 
National Veterinary Institute Bergen 
 
Abstract: 
 
Bacterial kidney disease (BKD) is a chronic disease of salmonid fish caused by the bacterium 
Renibacterium salmoninarum. The BKD-situation in Norway has been stable during the last 
decade, with only occasional outbreaks with limited mortality.   
 
BKD, number of sites/farms diagnosed  
 
 
 
A surveillance programme for BKD was initiated in autumn of 2005. Freshwater sites with 
salmonids and seawater sites with salmonid broodfish are sampled every other year (coordinated 
with VHS/IHN surveillance). Sampling is done by the Food Safety Authority. Kidney (+ other 
internal organs from fingerlings) is tested by ELISA using a monoclonal AB against surface protein 
p57 (BiosChile). ELISA positive samples are tested by real-time PCR.  
 
BKD surveillance programme, results 
 
 
 
In 2009, R. salmoninarum was not detected in the surveillance programme, but BKD was diagnosed 
in a total of 3 on-growing sites/farms, 2 rainbow trout and 1 Atlantic salmon.  These diagnosed 
were made on material submitted by local fish health services investigating clinical disease and 
increased mortality at the sites. Both rainbow trout farms were located in a fjord recognised as a 
recurrent “hot spot” for BKD. Follow up sampling from one rainbow trout farm revealed R. 
salmoninarum in sparse culture from 2 fish. These fish tested negative by ELISA and real-time 
PCR.  
 
This illustrates the limitations of surveillance programmes in detecting low prevalence disease.  
 
Minutes 
BKD historical data: BKD has been a considerable problem with the peak of more than 60 
outbreaks in one year (1990). 1980: first 5 cases in Norway, wild brood stock was the probable 
source of the infection. There is a wild reservoir. The most efficient control measure is brood stock 
screening with elimination of positive brood stock. The disease is notifiable. The last 10 years the 
situation has been stable with less than 5 outbreaks per year. The surveillance programme was 
started in 2005 with sampling of 30 fish from ongrowing facilities and 60 fish from broodstock 
farms. Single fish examined by ELISA. Positives are furthermore tested by in-house PCR. There 
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have been some problems with incomplete samplings. Details of the surveillance programme are 
available at the website in the annual reports. 
BKD recent outbreaks: BKD detected in 3 on-growing sites in 2009: 2 rainbow trout (in hotspot 
area close to Bergen) and 1 in Atlantic salmon (import from Iceland). 
 
Case 1: Submission to NVI Bergen by local fish health service; Mortality low-normal; Observed 
ulcer and boils; Suspect Flavobacterium psychrophilum; BKD detected (1 fish sent in); Later 
samplings: 19 fish all negative; Later sampling again: BKD diagnosed by growth on SKDM agar 
but not by PCR. 
Case 2: The fish had also meningitis where R. salmoninarum were detected.  
Active surveillance in 2009: 3701 fish tested negative 
Passive surveillance: 1 fish selected from a population > 60,000 tested positive 
 
Questions: 
Olga Haenen: Do you have an explanation why PCR is less sensitive than growth on SKDM? 
Hege Hellberg: Probably because BKD is very unevenly distributed. This is part of the reason. 
Mansour El-Matbouli: Did the ELISA positives have clinical signs? 
Hege Hellberg: Yes! 
Niels Jørgen Olesen: Concerning the risk factors for contracting BKD. We have in Denmark seen 
big problems in recirculation farms. Have you seen anything similar in Norway? 
Hege Hellberg: No, we have not seen something similar. 
Brit Hjeltnes: Recirculation is of limited but growing use in Norway. 
 
 
Red Mark Syndrome – a diagnostic challenge 
Stephen W. Feist, David Verner-Jeffreys and Birgit Oidtmann 
Cefas Weymouth Laboratory, Barrack Road, The Nothe, 
Weymouth, Dorset. DT4 8UB UK 
 
Abstract 
Red Mark Syndrome (RMS) has recently been reported in Great Britain and some other European 
countries and is having a significant impact on the trout aquaculture industry (mainly due to 
downgrading of carcasses at slaughter).  The number of farms affected by RMS in the UK has risen 
from less than 5 in the winter of 2003/2004, to approximately 80 farms, affecting more than 50% of 
the rainbow trout industry in the UK. The transmissible nature of the disease strongly suggests that 
a pathogenic agent is involved but to date this has not been identified. In North America the 
aetiology of a similar condition called Strawberry Disease is also unresolved but a recent study 
suggests the possible involvement of a Rickettsia-like organism. 
It is known that RMS is transmitted by live fish movements but with an unknown infectious 
aetiology many risk factors are associated with the condition remain undetermined.  Uncertainty 
regarding the nature of the aetiological agent makes diagnosis of the condition difficult and 
currently is heavily reliant on histopathological features.  Consequently, acquisition of reliable data 
on the epidemiology of the disease and investigation of potential control methods remains 
challenging.  This presentation provides a summary of the condition and compares the pathology of 
RMS and similar conditions such as Warm Water Strawberry Disease (WWSD), US Rash and US 
Strawberry Disease and highlights the urgent need to investigate RMS further as a significant 
emerging disease in Europe.  
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Minutes: 
Background: RMS is a skin condition of rainbow trout. First observed in the UK January 2004. 
May have a rickettsial involvement. Skin is affected to subdermal layer with moderate to marked 
inflammatory response. No systemic signs of infection. The diseases causes downgrading of 
carcasses. The fish can spontaneously recover. 
RMS epidemiology: First diagnosed in Scotland late 2003/early 2004. First observed in England in 
2005. Within a farm the condition can spread. 50% of annual production is now affected in the UK. 
The disease is also called coldwater strawberry disease (Warm water strawberry disease in the UK 
since 1998, summer condition, vitamin C responsive, looks like RMS). 
Aetiological agent: Epidemiology strongly suggest an infectious agent 
Case definition for a confirmed case of RMS (based on field observations and based on laboratory 
examination) has been put down by CEFAS.  
Epidemiological study: Case-control study performed with the aim to provide information that 
helps to prevent introduction into unaffected farms, manage the disease etc. Results: Fish pumped 
between units odds ratio 6.7, gastroenteritis odds ratio 15.22, there is still a lot to do 
Conclusions: The disease is caused by an infectious agent. There is a long incubation period. 
Virulence is questionable 
 
Questions: 
Olga Haenen: Also in Stirling they are working with RMS. One of the pictures you showed also 
looked quite the same as our first IHN outbreak. Maybe we have red mark syndrome attached to 
IHN. 
Steven W. Feist: We work together with Sterling. I am glad you do not suggest that we have IHN! 
Renate Johanson: When it is so difficult to find the agent I might look for microsporidia. We have 
a very nice test we are willing to share with you. 
Steven W. Feist: Thanks a lot. I can assure you I have already looked very hard to find 
microsporidia. 
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Characterisation of a Rosette Agent (Sphaerothecum destruens) from sunbleak (Leucaspius 
delineatus) in the UK. 
R. Paley*1, D. Andreou2, P.Martin1, D. Stone1, K. Bateman1, S. Irving1 and S. Feist1 
1Cefas, Weymouth, UK 
2Cardiff University, Cardiff, UK 
 
Abstract: 
Sunbleak (Leucaspius delineatus), a cyprinid fish native to continental Europe is experiencing 
population decline which appears to be linked to the spread of the invasive Asian cyprinid  
(Pseudorasbora parva).  Species interaction studies showed inhibition of spawning, wasting then 
death in L. delineatus cohabited with P. parva, or exposed to their holding water (Gozlan et al. 
2005).  Histological examination lead to the identification of an intracellular parasite, similar to the 
freshwater Mesomycetozoean parasite, Rosette agent (Sphaerothecum destruens) that infects 
salmonids in the USA.  Subsequent PCR and sequence analysis of a partial 18S rRNA gene 
demonstrated 100% homology.  S. destruens is capable of survival in fish in the marine 
environment and has been associated with sporadic severe infectious disease (occasionally 
mortalities up to 90%) of cage-reared Chinook salmon (Oncorhynchus tshawytscha) in North 
America (Elston et al. 1986; Arkush et al. 1998) and in farmed Atlantic salmon (Salmo salar) in 
freshwater in California (Hedrick et al. 1989).  In the US the disease is usually chronic and does not 
appear to impair spawning of infected fish.  Information on the impact on wild stocks is extremely 
limited.   This is the first identification of this parasite in the UK and from a cyprinid.  Given the 
potential for causing severe disease we have developed cell-culture of the sunbleak rosette agent for 
use in pathogenicity studies.  Sunbleak rosette agent spores are infective to EPC, CHSE and FHM 
cells replicating most rapidly in EPC cells. Spores can be induced to zoosporulate in water forming 
motile uni-flagellated zoospores in a temperature dependant manner.  Challenge experiments 
indicated the spores, when injected intraperitonealy, are able to replicate and disperse in Atlantic 
salmon and sunbleak and contribute to significant mortality.  
 
ARKUSH, K.D., FRASCA, S. (JR) AND HEDRICK R.P. (1998) PATHOLOGY ASSOCIATED WITH THE ROSETTE AGENT, A SYSTEMIC 
PROTEST INFECTING SALMONID FISHES.  J. AQUAT. ANIM. HEALTH. 10:1-11 
ELSTON R.A., HARRELL, L. AND WILKINSON M.T. (1986) ISOLATION AND IN VITRO CHARACTERIZATION OF CHINOOK SALMON 
(ONCORHYNCHUS TSHAWYTSCHA) ROSETTE AGENT. AQUACULTURE. 56:1-21 
Gozlan, R.E., St-Hilaire, S., Feist, S.W., Martin, P. and Kent, M.L.  (2005) Biodiversity: disease threat to European fish.  Nature. 
2005 435(7045):1046.  
HEDRICK, R.P., FRIEDMAN, C.S. AND MODIN, J.  (1989) SYSTEMIC INFECTION IN ATLANTIC SALMON SALMO SALAR WITH A 
DERMOCYSTIDIUM-LIKE SPECIES.  DIS. AQUAT. ORG. 7:171-177 
 
Minutes 
Rosette agent do cause severe disease in the USA and it is present in UK, but not severe until now. 
Background: Sunbleak populations decline is postulated to be linked to spread of invasive Asian 
fish. Is rosette agent part of this decline? 
The rosette agent, Sphaerothecum destruens, is an obligate intracellular parasite of class 
mesomycetozoea. It has a potential to cause severe disease. It can grow on cell cultures.  
How pathogenic is the rosette agent? Challenge experiments: IP injection of spores in salmon or 
sunbleak. It seems to cause mortality in salmon whereas in sunbleak it produced less mortality. No 
obvious external signs of disease. Internally nodules in organs (remember IP injection). Gram 
positive granules. Replication of zoospores in the kidney.  
Summary: 
First ID of rosette agent in the UK. No apparent species specificity. Capable of replication within 
salmon and sunbleak and producing mortality 
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Questions: 
Mansour El-Matbouli: Are there any therapy? 
Richard Paley: This disease has only caused serious problems few times in the states, so nobody 
has really worked on this issue. 
 
 
 
 
Biosecurity risks associated with EUS and Iridovirus in ornamental fishes 
M. El-Matbouli; M. Saleh; H. Soliman 
Fish Medicine and Livestock Management; Department of Farm Animal and Veterinary Public Health; University of 
Veterinary Medicine, Vienna, Austria 
 
Abstract: 
 
Global trade of ornamental fishes is unique in that while many countries impose strict requirements 
on nearly all imported animal and plant products, live ornamental fishes are commonly imported in 
large volumes without similar controls. The risk associated with importation of gouramis and 
cichlids, especially in relation to epizootic ulcerative syndrome (EUS) and iridovirus is of concern. 
We investigated 93 ornamental fish imported from different countries into the EU and concluded 
there were inadequate procedures in place to regulate importation of live ornamental fish. Irido-
virus and Aphanomyces invadans were detected in multiple fish, despite these fish being 
accompanied with certificates from the country of origin to confirm they were free from EUS and 
Irido-viruses. Both  of these organisms are exotic to the EU and there are no reports of their 
presence in EU-aquaculture. Without urgent action to regulate the importation of live ornamental 
fish, a significant risk exists to EU-aquaculture from exotic diseases and their subsequent serious 
economic impacts.     
 
 
 
Minutes 
I will now present a case report that I want to discuss with you.  
EUS has been reported from 24 countries on four continents (North America, southern Africa, Asia 
and Australia). 76 fish species have been confirmed to be naturally affected by EUS. European 
catfish, rainbow trout, and goldfish are susceptible to the agent causing EUS Aphanomyces 
invadans. European countries are supposed to be free from EUS. 
EHNV have not been reported to occur in freshwater ornamental fish. 
As ornamental fish dealers do not like us to examine their fish for listed diseases we decided to buy 
fish and examine them ourselves for EUS and iridoviruses. We bought Trichogaster and brought 
them to the laboratory. After 14 days they started to show clinical signs corresponding to EUS. 
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Pieces of affected muscle were placed on agar to grow the fungus. The PCR was performed on 
isolates grown on agar and on fish tissue. A. Invadans positive samples were found. The PCR 
protocol used was according to Vandersea et al. 2006. 
Detection of iridovirus was done by PCR according to protocol by Go el al. 2006, which cannot 
identify EHNV. We also tested the samples using the EHNV primers recommended by the OIE. 
None of the samples were positive by the OIE primers. The iridovirus positive fish were tested 
according to a protocol that do not detect EHNV. 
The fish had health certification that they were free of EUS and EHNV.  
Conclusion: The risk associated with the import of gouramis and cichlids especially in relation to 
EUS and iridovirus is of concern. The import of asymptomatic carriers will continue to be a 
problem until robust rapid diagnostic techniques are developed and used as basis for health 
certification. Ensuring that infected fish and water with the infectious agent do not come into 
contact with fish culture ponds could help prevent the spread of EUS to Europe. 
 
 
Questions: 
Birgit Oidtmann: How did you select the fish that you bought? 
Mansour El-Matbouli: I did not select them at all. We just bought the fish. We did not want the 
sales person to know what we wanted to do. We kept the fish in the laboratory for at least 2 weeks 
before examining them. 
Heike Schütze: For iridovirus diagnostics, have you ever isolated the virus on cell culture? 
Mansour El-Matbouli: We tried to grow them in cell culture without luck. 
Giuseppe Bovo: Did you identify the iridovirus at genus level or as species?  
Mansour El-Matbouli: We sequenced the products and we only know it is iridoviruses. 
Olga Haenen: Did you inform the EU? 
Mansour El-Matbouli: I cannot keep this information for myself that is why I wanted to share this 
information with you and discuss what to do. The importers want us to make bacteriological 
investigations only. 
Sigrid Cabot: Ornamental fish diseases are of concern. The emphasis put on this is illustrated by 
the fact that the Food and Veterinary Office of DG SANCO has so far visited only a few third 
countries as regards Aquatic animal health and the first three ones were Malaysia, Singapore and 
Thailand, countries which are all important actors in the field of ornamental fish. I would also like 
to highlight that there is a general obligation for everyone working with aquaculture animals to 
report suspicions of outbreaks of listed diseases.  
 
 
  
Report on the 14th Annual Meeting of the National Reference Laboratories for Fish Diseases Copenhagen, Denmark May 26-28, 2010 
 
Page 35of 67 
 
SESSION II: Technical issues related to sampling and diagnosis  
 
The new EU manuals on sampling and diagnostic procedures and the role of the www.CRL-
fish.eu web page  
Niels Jørgen Olesen and Helle Frank Skall 
National Veterinary Institute, Technical University of Denmark  
 
Abstract: 
The development of a draft COMMISSION DECISION of Diagnostic Manual for certain aquatic 
animal diseases has been in process in the recent years. The background for this is  
1. A decision in order to ensure uniform procedures for surveillance schemes, including 
health inspections and sampling, and diagnosis of the diseases listed in Annex IV to 
Directive 2006/88/EC,  
              The Decision sets out:  
              (a) minimum requirements for surveillance schemes and diagnostic methods that shall 
be used by Member States to obtain disease-free status for the whole territory of 
the Member State, zones or compartments;  
              (b) minimum requirements for surveillance schemes and diagnostic methods that shall 
be used by Member States to maintain the disease-free status for the whole 
territory of the Member State, zones or compartments; 
              (c) minimum requirements and criteria for the evaluation of the results for diagnostic 
methods to be performed in the case of suspicion and to confirm the presence of 
the listed diseases.  
2. This Decision is directed towards both the authorities responsible for the control of those 
diseases and the laboratory personnel performing the tests with regard to those diseases. 
Accordingly, emphasis is put on the sampling procedures, principles and applications of 
laboratory tests and evaluation of their results. 
3. The confirmation of the listed diseases in aquatic animals must be in accordance with the 
guidelines minimum requirements and criteria for the evaluation of the results for 
diagnostic methods set out in this diagnostic manual. 
 
The decision on a Diagnostic Manual will thus cover all the exotic and non-exotic fish and molluscs 
diseases covered in Directive 2006/88/EC and both sampling and diagnostic procedures will be 
included. In order to reduce and to perform a more flexibel set of guidelines the new decision refers 
to the websites of the respective CRL for the detailed diagnostic procedures that shall be followed. 
The procedures will be very similar to the procedures given in previous Commission Decisions on 
VHS, IHN and ISA, respectively. 
 
Minutes 
The final working paper of the Comission decision is in process. In comparison with the previous 
legislation this paper will cover both molluscs and fish within separate annexes and cover both 
exotic and non exotic diseases. The methods put on the CRL webpage will be closely linked to the 
methods described in the OIE guidelines. The structure of the parts for the specific diseases will 
follow a common frame I: Description of the aetiology. II: Provisions on how to obtain and 
maintain certain health status; surveillance programs, eradication, maintaining and regaining 
disease free status. III: Diagnostic methods; sampling procedure, methods for surveillance in 
disease free areas and methods for surveillance/diagnostics in endemic areas or if suspicion of 
disease. 
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Questions. 
Guiseppe Bovo: Will the Commission decision be part of the CRL website? 
Sigrid Cabot: No, the Decision will be adopted by the Commission and published as a 
Commission Decision in the Official Journal, with links to the CRL webpage. 
Sigrid Cabot: There will be some fine tuning and then the draft will be sent to Member States for 
review. Please take active part in this process and comment on the draft Decision. 
 
 
 
 
Diagnostic procedures for VHS, IHN, and EHN  
Helle Frank Skall, Søren Kahns, Ellen Ariel & Niels Jørgen Olesen  
National Veterinary Institute, Technical University of Denmark  
  
Minutes 
VHSV/IHNV 
The diagnostic procedures for VHS and IHN are as you know them.  
During transport the samples should not exceed at temperature higher than 10°C and ice should still 
be at least partly present in at least one of the freeze blocks at arrival at the laboratory.  
The virological examination should start as soon as possible and no later than 48 h after sampling. 
In exceptional cases this can be extended to 72 h. 
In case of practical difficulties freezing for up to 14 days of organ material in cell culture medium at 
-20°C can be allowed. Likewise is it allowed to freeze the supernatant after homogenisation for up 
to 14 days at -80°C in case of e.g. incubator breakdown. 
Culture shall be performed on BF-2 or RTG-2 and either EPC or FHM cell lines. At inoculation the 
cell lines shall be young and actively growing.  
The end dilution of inoculation shall be 1:100 and 1:1000, respectively and at least 2 cm2 of cell 
area for each dilution, this corresponds to the well size in a 24 well plate. Subcultivation after 7-10 
days and final reading again after 7-10 days. Toxic effects should not be present at final reading.  
If cytopathogen effect is observed identification of VHS or IHN shall be done by neutralisation, 
IFAT, ELISA or RT-PCR.  
Applied diagnostic methods to rule out and confirm VHS and IHN are I: VHSV/IHNV isolation in 
cell culture. II: VHSV/IHNV detected in tissues by immunoassay. III: VHSV/IHNV detection by 
RT-PCR followed by sequencing. Disease is considered confirmed if one or more of the diagnostic 
methods are positive for VHSV or IHNV. Confirmation of the first case of VHS/IHN in an area 
previously not infected shall be based on method I, whereas diagnosis based solely on method II or 
III only applies for endemic areas.  
 
EHNV 
The CRL diagnostic manual for EHN differs slightly from the manual presented by the OIE. The 
differences are based on a cost-benefit analysis. If we can’t use the same procedures as we use for 
VHS and IHN it will cost an enormous amount of money to survey for this disease.  
The OIE reference laboratory recommends kidney, liver and spleen. As 2 of these organs are 
already included in the samples taken for VHS and IHN, we believe it will be OK to use these 
samples for both purposes. 
In order to investigate the growth preferences for EHNV the reference isolate was propagated on 
EPC cells at 20°C and titrated and incubated at 10°C, 15ºC, 20ºC, 24ºC og 28°C, respectively. The 
trays were read after 3, 5, 7, 10 and 14 days. 
Report on the 14th Annual Meeting of the National Reference Laboratories for Fish Diseases Copenhagen, Denmark May 26-28, 2010 
 
Page 37of 67 
 
On BF-2, EPC and RTG-2 cells the titer reached 108 TCID50/ml after 7-10 days, whereas on FHM 
cells the titer is lower at 105 TCID50/ml. The final titer is the same in the temperature interval 15-
24°C, but titer rise is fastest at 20-24°C.  
In order to examine which organs are best to use for isolation of EHNV and to examine if the 
culture method used for VHS/IHN is acceptable, an infection trial was performed by Dr. Ellen 
Ariel.  
• EHNV was passed 3 x in vivo by IP injection in perch with re-isolation in EPC cells at 
20°C.  
• Perch were IP injected with 50 µl of EHNV, conc. 104 TCID50/ml  
• Dead fish were frozen at -20°C till the end of trial  
• Brain, heart, head kidney, spleen, liver, gills and tail musculature were collected and  
homogenized separately and inoculated on cell cultures  
• The samples were examined on cell cultures by 3 methods  
1) 1 x 14 days + 1 x 7 days at  22°C 
2) 1 x 14 days + 1 x 7 days at  15°C 
3) 1 x 7 days + 1 x 7 days at  15°C 
The single most suitable organ for reisolation of EHNV was kidney and regarding number of 
reisolations method 1 > method 2 > method 3. So the 2 x 7 days method with incubation at 15°C is 
not the optimal method for detection of EHN, as only 53% of the positive fish were tested positive.  
But since the diagnostics is based on several fish, preferably with symptoms we suggest that the 
method already used for VHSV/IHNV is appropriate also for EHNV even though it differs from the 
OIE manual.   
For confirmation of EHNV in case of CPE, IFAT and PCR followed by sequencing of amplicon is 
used. However one should be aware that the available antibodies against EHNV cannot distinguish 
between this and other rana viruses.  
 
 
Questions: 
Birgit Oidtmann: What is considered endemic? 
Niels Jørgen Olesen: Category 3 and worse! 
Guiseppe Bovo: This should be clarified! 
Sven M. Bergmann: Why sequence EHNV? 
Helle Frank Skall: EHNV is notifiable as an exotic disease whereas other rana viruses are not.  
Heike Schütze? Why this difference in legislation? 
No real conclusion, people agreed that the viruses were very close. 
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Molecular diagnostic procedures for KHV - conclusions and recommendations from EPIZONE 
workshop on KHV 
Marc Engelsma 
 
Abstract: 
 
The use of molecular tools is now widespread in life science and PCR based assays are more and 
more used as diagnostic tools. In general PCR assays are very powerful, sensitive techniques. 
Because of this specific precautions need to be taken to minimize the risk of cross-contamination, 
inducing false positive results. This was demonstrated especially during the latest ring trial 
organised by CEFAS in 2008. The participating laboratories were challenged to detect koi 
herpesvirus (KHV) in five ampoules by PCR. The results showed a considerable number of labs 
having problems of false positive samples. During an EPIZONE workshop, November 12-13 2009, 
at the Central Veterinary Institute (Lelystad, the Netherlands) pitfalls and precautions of using PCR 
assays in diagnostic laboratories were discussed, with a focus on PCR assays for detecting KHV. 
The report from the workshop gives an overview and remarks on the currently used PCR techniques 
and assays for detection of KHV. Furthermore, the reliability of the diagnosis is not only dependent 
on the test itself; it is also dependent on the processing and handling of the samples in order to 
prevention of cross-contamination between samples. The report gives a general protocol for 
handling diagnostic specimens prior to PCR analyses in order to limit the risk of cross-
contamination. 
 
Minutes 
 
The PCR technique is characterised by its high sensitivity and specificity. However pitfalls lie also 
in the sensitivity since this is prone to cross-contamination, and in the specificity since this only 
detects agents within a range of primers. Moreover it is detection of an agent not necessarily the 
disease. During the CEFAS KHV ringtrial 10 of 44 laboratories produced false negative and 19 of 
44 laboratories produced false positive results. During an Epizone workshop on the topic in 
Lelystad, NL, the problems were discussed. The aim of the Workshop was to produce 
recommendations on handling diagnostic specimens to limit the risk of cross contamination and to 
review the current PCR assays used. To control the flow of the specimen through; Sampling, DNA 
extraction, Mix preparation, PCR run and gel electrophoresis is essential to prevent contamination 
between and within these steps. Keep sampling, mix preparation, DNA extraction and PCR run in 
separate rooms and use separate coats and equipments and control entrance of people and reagents 
to each room. Quality of sample material determines parts of the test sensitivity, prolonged time at 
about 20o C, stress before sampling, target organs: gill and kidney. Sensitivity might be reduced 
when pooling samples. Following the CEFAS ring trial most correct results were after the use of 
silica matrix based methods. PCR methods available for KHV detection:  Isothermal PCR: limitedly 
used in diagnostic laboratories. Conventional PCR: Bercovier and Gray OIE recommended 
methods. Nested PCR: High sensitivity but also higher risk of cross-contamination. Semi-nested: 
Bergmann. Real time PCR: High sensitivity, limited risk of cross-contamination, high costs. In 
diseased fish the published PCR assays for detection of KHV are suitable; however the most 
sensitive assay is recommended. For surveillance: Real time PCR seems to be the most optimal. 
 
Questions 
Søren Kahns: How do purification kits perform with regard to sensitivity? 
Marc Engelsma: Phenol Chloroform based kits produce high yields in the extraction process 
however they seem not to be very constant in their performance! 
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Mansour El-Matbouli: How to interpret cases where a positive result is only seen with nested 
PCR? 
The use of nested PCR was discussed without any conclusion. 
Marc Engelsma: It depends on the final goal and whether false positive or negative is of more 
concern. Optimal sampling procedure could overcome the sensitivity issue and optimal laboratory 
work flow and the use of many negative controls could overcome the specificity issue of the nested 
PCR. 
 
 
Standard Diagnostic Procedures for ISA testing undertaken by Marine Scotland 
Eann Munro 
Marine Scotland Science, Marine Laboratory, 375 Victoria Road, Aberdeen, Scotland 
 
Abstract: 
At Marine Scotland, the diagnosis of infectious salmon anaemia (ISA) is carried out as approved by 
the World Organisation for Animal Health (OIE 2009), by studying both clinical and pathological 
features as well as direct methods for detection of the viral pathogen. External clinical signs of 
disease include pale gills, exophthalmus, ocular haemorrhage and slight abdominal distension. 
Internally, ascites and a dark coloured liver are common in ISA infected fish. A drop in haematocrit 
value is also recorded.  
Where ISA disease is suspected, MSS fish health inspectors collect tissue samples for the following 
diagnostic assays:- Histopathology confirmed by immunohistochemistry (IHC); isolation of the 
virus in cell culture followed by an indirect fluorescent antibody test (IFAT), kidney imprints for 
IFAT screening and real-time RT-PCR (qRT-PCR) with positive samples confirmed as ISAV by 
nucleotide sequence analysis. 
According to EU Commission Decision 2003/466/EC, ISA is only confirmed if clinical signs and/or 
pathological changes consistent with the virus are present and/or detection of the agent is verified 
by two or more of the independent tests described above (Table 1). 
 
Table 1 - Combination of tests that provide official confirmation of ISA 
 
 
Minutes 
Upon inspection of farms a minimum of 5 and up to 30 fish are sampled. If suspect results are 
obtained but without sufficient data to confirm the results, a second sampling of 150 fish is carried 
out. Marine Scotland Science has an ongoing project to evaluate and define the sensitivity and 
specificity of the diagnostic approach. 
 
Questions:  
Marc Engelsma: Does HPR0 give protection? 
Eann Munro: I don’t know, but we have not seen dual infections. They have different tissue/cell 
tropisms and are fundamentally different strains regarding their appearance in vivo.  
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Diagnosis of Aphanomyces invadans (Epizootic Ulcerative Syndrome, EUS) 
Birgit Oidtmann, 
Cefas Weymouth Laboratory, Barrack Road, Weymouth, Dorset, DT4 8UB, UK 
 
Abstract: 
Epizootic Ulcerative Syndrome is currently considered exotic to Europe. However, live ornamental 
fish are imported from countries where the pathogen is known to occur. Therefore there is a real 
risk that the pathogen will eventually arrive in Europe. In order to detect the disease if introduced, 
national reference laboratories need to capable of diagnosing the disease.  
 
There are a number of laboratory tests available, including isolation, histopathology and PCR. The 
advantages and disadvantages of each of the methods and their suitability for purpose will be 
discussed. Furthermore, competent authorities will need to devise an approach for deciding on when 
a disease event in a fish population is considered a suspect case that should be investigated by 
suitable laboratory methods. The issue of developing a suitable case definition of a suspect case and 
a confirmed case will be discussed.  
 
Minutes 
The Oomycete Aphanomyces invadans is suspected to be the causal agent of Epizootic Ulcerative 
Syndrome (EUS). In the EFSA journal a survey has been published on susceptible species. This 
definition relies upon recognition of the agent and includes 32 species in 29 genera. However 
further 190 species in 90 genera is suspected to be susceptible but there has been uncertainty about 
the correct agent. However the agent certainly seems to have little species specificity, and the list is 
most likely not complete. 
A suspect case of EUS according to the OIE diagnostic manual 2009 is related to typical lesions in 
susceptible fish or presence of Aphanomyces sp. without further identification. A confirmed case is 
a suspect case presenting typical mycotic granulomas in tissue or where the agent has been 
identified by PCR or FISH detection techniques in tissue or where A. invadans has been isolated 
and confirmed by either bioassay, PCR or sequence analysis. According to the OIE diagnostic 
manual from 2006 both pathology and verification of the agent should be present before a definitive 
diagnosis, in that context the definition of a confirmed case has become somewhat more loose.  
Sampling should be done from various lesions and organs and should be done in the edge of a 
lesion from a clean cut surface. A variation in pathology and clinics is seen in between cases, 
especially formation of granulomas cannot always be expected - this depends upon variable factors 
such as stage of infection, age and type of fish etc. There are three PCR methods published 
“Oidtmann”, “Vandersea” which is specific and “Phadee” which can cross react with other 
Aphanomyces spp. and which also don’t amplify all strains of A. invadans. Of the Oidtmann 
andVandersea, Oidtmann produces a somewhat longer PCR product which is suitable for 
sequencing.  
Following the typical clinics with ulcers and the likely absence or low prevalence of EUS in 
traditional aquaculture it might not be the most rational way to raise suspicion upon the observation 
of ulcers. Another approach could be within a limited period of time to do a targeted sampling in 
farms from fish with skin lesions.   
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Council Directive 2006/88/EC: The concept of increased mortality and how to deal with it from 
a legislative perspective 
Sigrid Cabot,  
DG SANCO, European Commission 
 
Abstract: 
 
Council Directive 2006/88/EC lays down minimum preventive measures aimed at increasing the 
awareness and preparedness of competent authorities and the aquaculture industry of diseases in 
aquaculture animals and minimum control measures to be applied in the case of an outbreak of 
certain aquatic diseases.  
 
Early detection of disease constitutes an essential part of an efficient and cost effective disease 
control strategy. For this purpose the Directive require all aquaculture production businesses 
(APBs) to keep records of mortality in each epidemiological unit as relevant for the type of 
production (Art. 8). Similar requirements apply to transporters of aquaculture animals. All APBs 
must also establish a risk based animal health surveillance scheme (Art. 10) which shall aim at the 
detection of any increased mortality in all farms and mollusc farming areas as appropriate for the 
type of production and of the listed diseases.  
 
The term increased mortality is defined in Annex I to the Directive as “unexplained moralities 
significantly above the level of what is considered to be normal for the farm or mollusc farming 
area in question under the prevailing conditions. What is considered to be increased mortality shall 
be decided in cooperation between the farmer and the competent authority.” 
 
When increased mortality occurs, it must immediately be notified to the competent authority or a 
private veterinarian for further investigation (Article 26).  
 
If the further investigation leads to a suspicion/confirmation of a listed disease it must be notified to 
the competent authority (Article 26), which will conduct further investigations as appropriate and 
take the appropriate measures relevant to the disease status of the area in which the listed disease 
was detected. 
 
Should the investigation lead to the conclusion that the increased mortalities are caused by an 
emerging disease, the competent authority shall to take appropriate measures and inform the 
European Commission, other Member States and EFTA Member States thereof (Article 41).  
 
Should the increased mortalities be caused by other diseases that those listed, Article 43 of the 
Directive gives a legal basis to under specific conditions to take national measures. 
 
Directive 2006/88/EC lays also down harmonised placing on the market and import requirements 
for aquaculture animals. According to these rules, aquaculture animals may not be placed on the 
market for further farming if they are not clinically healthy or originate from a farm or mollusc 
farming area where there is any unresolved increased mortality (Article 15). 
 
Minutes 
Everyone with an occupational relationship with aquaculture animals have an obligation to notify 
increased mortalities and suspicion of listed diseases: farmers, veterinarians, veterinary authorities, 
transport- and slaughterhouse personnel. What is to be considered as increased mortality should be 
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determined on a farm-to-farm basis in cooperation between the aquaculture production business and 
the competent authorities. 
 
Questions 
Q: What should be done if mortality is seen in a closed ornamental facility? 
Sigrid Cabot: Only parts of the directive apply to closed ornamental facilities. However, Article 26 
on notification of increased mortalities and suspicion of listed diseases does apply. 
Brit Hjeltnes: There might be differences in fish species and farms with regard to increased 
mortality. “In cooperation with the farmer” might not always be optimal. 
Sigrid Cabot: This should be dealt with by the competent authorities. Considerations on the 
particularities of the farm in question need to be taking into account. However, individual farmers 
which have high background mortality due to poor management practices should not be rewarded. 
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Un-explained increased mortality in fish farming – a practical approach. Experiences from 
Norway 
Hege Hellberg, 
National Veterinary Institute 
 
Abstract: 
Investigation of un-explained increased mortality in fish farming is crucial to detect and control fish 
diseases. This presentation will give an overview of the organisation of fish health monitoring in 
Norway with examples from recent disease cases, including infectious salmon anaemia (ISA) and 
pancreas disease (PD).  
 
A short review of the development and structure of fish health management in Norway prior to 
harmonisation with EU legislation will be given to provide background for the present organisation 
of fish health monitoring in Norway. 
 
 
As part of licensing requirements, all fish farms must have a contract with an approved fish health 
service. These are private companies (veterinarians or fish health biologists) specialising in 
diagnosis, prevention and treatment of fish diseases. On-growing farms with > 50 000 fish must 
have at least 6 health control visits annually and brood stock farms > 50 fish a minimum of 12 visits 
a year.  
  
The Norwegian Food Safety Authority is the Competent Authority on aquatic animal diseases. The 
NFSA monitors mortality in fish farms through monthly, web-based reports supplied by the fish 
farmers. Increased mortality and suspicion of listed diseases must be reported immediately. In 
addition, fish health services and laboratories are required to report any suspicion or diagnosis of 
listed diseases.  
 
In cases of increased mortality, the NFSA (or fish health personnel appointed by the NFSA) 
inspects the farms. Records are checked, clinical examination and sampling of the fish is performed 
and samples submitted to the National Veterinary Institute or other approved laboratories for 
analysis. In addition to these ad-hoc inspections, the NFSA visits all on-growing farms annually in 
connection with surveillance programmes. Brood stock farms and hatcheries are inspected at a 
higher frequency.  
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Minutes 
The early history of the Norwegian fish health management has its background in a tight network 
formed under the ministry of agriculture, aimed at supporting production by sampling, surveillance 
diagnose and control treatable diseases such as furunculosis. This in turn initiated regulations upon 
the aquaculture business. Today the legislation is placed under the ministry of fisheries and the food 
safety authorities, and in addition to the direct support for the farmer a broader food-chain and more 
proactive approach is applied. Several instances is interacting from farmers, private veterinary 
companies to veterinary authorities, private and official laboratories to survey and diagnose all with 
the responsibility to report within the national regulative. 
Contract with an approved fish health service is required in licensing a fish farm. This includes 
onside diagnosis and treatment and management advice. Further there is detailed requirements in 
the regulation on operation an aquaculture establishments including: Keeping records, reporting, 
qualifications, production plan and contingency plan to be approved by the food safety authorities. 
The food safety authorities recieves reports from farmers and fish health services and follow up by 
doing annual inspections checking records and sampling for surveillance programs and also ad hoc 
inspections based on reports deviant reports or missing reports.  
Example VHS: Rainbow trout farm-increased mortality - farmer calls local fish health service for 
diagnosis – VHS suspicion raised - sampling and diagnosis by the National Veterinary Institute - 
restrictions – confirmation of diagnosis by the CRL – fallowing of pens. 
Example ISA: Salmon farm – reports on increased mortality – food safety authorities initiate 
inspection – 90% mortality, signs of circulatory disturbances, suspicion of ISA is raised – fish sent 
to the National Veterinary Institute - following laboratory work pancreas disease was diagnosed but 
not ISA. 
Success of a controle and surveillance system relies upon qualified personnel on all levels and 
reliable methods. 
 
Questions.  
Guiseppe Bovo: It is a good system which have proven itself. However, in other countries there 
seems to be big differences in implementing such systems in between countries. 
Olga Haenen: We had three cases of IHN, however the authorities didn’t financially compensate 
the farmer and had no interest in gaining a IHN free status in our country, so, subsequently no 
obligatory stamping out occurred. 
Hege Hellberg: How to deal very much depends on the circumstances in your country, the 
economic impact etc.    
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Diagnostic sensitivity and specificity of test procedures for Renibacterium salmoninarum in 
rainbow trout 
L.M. Hall & A.G. Murray 
Marine Scotland Science, Aberdeen, UK. 
 
Anstract: 
 
Renibacterium salmoninarum is the causative agent of bacterial kidney disease (BKD), a condition 
which affects rainbow trout and other salmonid fish.  Scotland has a surveillance programme which 
uses bacterial culture, ELISA and qPCR to test for infected farm sites. We have compared the 
reliability of these test procedures using 2700 rainbow trout sampled from a single farm-site which, 
although not showing signs of disease at the time of sampling, has a history of BKD.  Latent Class 
Analysis of the categorical test results was used to evaluate the diagnostic sensitivity and specificity 
of the test procedures for individual and pooled groups of fish. Quantitative values were also used 
to further investigate the effect of pooling. This work has provided information which will be useful 
for improving the current surveillance programme and informing policy. 
 
Minutes 
Specificity for all tests seems to be around 99% on single fish, sensitivity on the other hand varies; 
culture: 5%, ELISA: 25%, qPCR: 99%. On pooled samples sensitivity decreases; ELISA. 6% 
qPCR: 36%, culture cannot be done on pooled material. Current practise is ELISA based; 30 fish in 
5 fish pools, if ELISA is positive confirmatory growth is performed on 150 fish. However this 
practice is time and labour consuming and costly. We are considering changing this to a future 
practice involving qPCR on 30 fish in 5 fish pools and if positive, confirmatory ELISA on 150 fish 
in pools of 5 fish. The future practice will be more cost effective, confirmatory result will be 
available more quickly with no compromise in sensitivity and specificity. 
 
Questions 
Brit Hjeltnes: qPCR as a screening – further confirmation, why? 
Malcolm Hall: We will not make a definitive diagnosis on one test, we need a confirmatory result! 
Hege Hellberg: Why pool samples? 
Malcolm Hall: The costs! 
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Non-lethal sampling and virus detection in fish latently infected with koi herpesvirus (KHV) 
Sven M. Bergmann* (D), Niels Jørgen Olesen (DK), Jeannette Castric (F), Eva Jansson (S), Marek Matras (P), Marc 
Engelsma (NL), Keith Way (UK) and Giuseppe Bovo (I) 
*Friedrich-Loeffler-Institut (FLI), German Reference Laboratory for KHVD, Federal Research Institute for Animal 
Health, Südufer 10, 17493 Greifswald-Insel Riems, Germany 
 
Within the EU project “EPIZONE” two projects touch farmed aquatic animals. These are:  
1. “WP 6.1. Surveillance and Epidemiology of emerging viral diseases in aquaculture”, headed by N.J. Olesen 
(Denmark) 
2. “Development of serological methods for detection of Koi herpes virus (KHV) antibodies in carp, Cyprinus 
carpio” (KHV-Sero), headed by J. Castric (France)  
 
Abstract: 
The first task of the German Reference Laboratory for Koi Herpesvirus Disease (NRL KHVD) was 
to develop new, highly sensitive methods for KHV detection in latently / persistently infected 
carrier fish (WP 6.1.) as well as non-lethal sampling methods. The second task was to produce 
antisera against KHV and other aquatic herpesviruses for assessment by serum neutralization assay 
(SNT) and antibody ELISA (KHV-Sero). 
Especially in latently / persistently infected fish virus concentrations between 5 to 10 KHV DNA 
genomic equivalents seem to be common in organ tissues, skin and gill swabs as well as in 
separated leukocytes. To increase virus replication in healthy-looking, but definitely KHV infected 
carp (60 – 75 d p.i.), these fish were netted for 1 min to simulate transportation and then set back 
into the same basin. Daily, gill swabs and droppings were tested after DNA extraction for KHV 
presence by different PCRs, a real-time PCR and different (semi-)-nested PCRs. It was shown that 
the KHV concentration in gill swabs increased between factors 100 and 1000 after netting for 2 to 4 
days. After a period of 5 to 7 days, virus release via the gills stopped. In droppings, KHV was 
detectable by real-time PCR only on day 3 after netting. These fish did not show any clinical signs 
of KHVD anymore over this one week period of sampling. As controls, latently KHV infected and 
non-infected control fish, were caught and sampled once, and the droppings from these basins were 
tested in the same manner. 
In the frame of the “KHV-Sero” project, mainly animal experiments and serological assay 
developments were carried out. One experiment focussed on sera against different aquatic 
herpesviruses (KHV, HVA, CCV and carp pox virus). These sera were sent out to 7 project partners 
for testing. All sera were tested by two different SNT (against homologous and heterologous 
viruses) and by a KHV antibody ELISA. 
While sera against KHV, HVA and carp pox virus reacted only with the homologous agents by 
SNT, one serum from the CCV group also reacted in KHV antibody ELISA. Additionally, CCV 
was the only agent which did not induce a neutralizing activity in carp over 8 weeks. 
*sven.bergmann@fli.bund.de 
 
Minutes 
Incubation time for development of disease when infected with KHV varies depending on several 
factors. The time frame can be from a few days to several weeks or months. Following contact 
infection, disease was observed to occur until two months after exposure. Exposing carps to stress 
induces viremia and increase in viral load throughout the body within 1-3 days. When sampling 
possible carriers, inducing stress prior to sampling might increase the chance of finding carrier fish. 
According to the OIE manual, it is OK to pool up to two fish when fish is diseased and up to 5 
when doing surveillance. However, this should be the other way around; a maximum of 2 fish 
should be pooled when monitoring whether a pool sample of up to 5 fish could be allowed when 
disease is present, where the amount of KHV virus would be expected to be high.  
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In 2000 the published PCR’s all seemed to perform satisfyingly. From 2005 the Bercovier PCR did 
not seem to perform in all cases and in 2008 the Gilad and the qPCR didn’t seem to work in all 
cases either. In 2009 our PCR still seem to perform in all cases. I believe the development in 
sensitivity among published PCR’s is attributed to development of genetic strain differences of 
KHV. 
 
Questions 
Mansour El-Matbouli: How many fish should you sample when dealing with ornamental koi. 
Birgit Oidtmann: You should report the findings in an objective manner, what did you find and 
how can this be interpreted with regard to the total population sampled!  
 
 
 
Cyprinid herpesvirus 3: to be, or not to be. 
Marc Engelsma, Michal Voorbergen-Laarman 
 
Abstract: 
 
Cyprinid herpesvirus 3 (CyHV-3), also known as koi herpesvirus (KHV), is a devastating virus in 
the culture of common carp and ornamental koi. In the last decade the virus has spread rapidly over 
the globe to major carp culture areas. Thus far the complete genome of three CyHV-3 isolates from 
different geographical locations has been sequenced showing only very limited differences in the 
genome sequences of these three isolates. At the Central Veterinary Institute, Lelystad, the 
Netherlands, an in house real time PCR assay is used for the detection of CyHV-3. As part of the 
validation of the assay, results obtained by the real time PCR assay from a large number of field 
samples were compared with results of the conventional assay as described by Bercovier et al. 
(2005). Mismatches in the results between the assays (real time PCR positive, conventional PCR 
negative) were nearly all very weak positive samples and could be attributed to higher sensitivity of 
the real time PCR assay. Sequencing of amplicons generated with general cyprinid herpesvirus 
primers (developed by CEFAS), the polymerase gene and major capsid protein gene were 
confirmed to be identical to the described CyHV-3 isolates. However, in three cases sequences were 
detected with approximately 96% identity to the polymerase gene and 97% identity to the major 
capsid protein gene. The koi bearing these viruses were clinically healthy and originated from areas 
with no actual CyHV-3 outbreak. Thus far we have not been successful to isolate a CyHV-3 variant 
from these koi. It is therefore difficult to assess the implication of these CyHV-3 variants for the 
carp and the diagnostics of CyHV-3 
 
Questions 
Laurent Bigarré: Could it be the vaccine strain you are looking at? 
Marc Engelsma: No, the variation was too big. Furthermore, the koi’s in question came directly 
from Japan where no vaccines are used! 
Sven M. Bergmann: Did you try to compare with the capsid gene? 
Marc Engelsma: Yes, it found those as well! 
Søren Kahns: Do you know anything about the pathogenecity of this strain?  
Marc Engelsma: I think it is a virus adapted to carp and I don’t know if it is pathogenic. It might 
be the original KHV virus from where the pathogenic KHV strain is developed! 
Richard Paley: We do not know if it is pathogen but we isolated this strain from diseases fish. 
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A novel Real-time PCR assays detecting all VHSV genotypes 
Søren Peter Jonstrup 
1National Veterinary Institute, Technical University of Denmark  
 
Abstract: 
 
The Rhabdovirus Viral Haemorrhagic Septicaemia Virus (VHSV) is a serious threat to many fish 
farmers of salmonid fish. To prevent outbreaks it is important to have a fast, sensitive, and specific 
diagnostic tool to identify infected fish. Traditional diagnosis based on isolation in cell culture 
followed by ELISA is sensitive and specific but rather slow. PCR based techniques are fast but so 
far no PCR has been developed that specifically detects all VHSV genotypes with a sensitivity 
comparable to traditional diagnosis. Here we present a Taqman based real time RT-PCR that detects 
all VHSV isolates in a panel of 79 VHSV isolates covering all known genotypes and subtypes and 
not 15 samples of related vira. The sensitivity of the PCR is comparable to traditional cell based 
diagnosis and it is possible to make a correct diagnosis within one work day. 
 
 
Minutes 
There is a demand for a PCR to do VHSV diagnostics directly on tissue samples. Matejusova et al. 
2008 have published a qPCR covering genotype I to III. However there is a need to develop a 
method that performs well on all genotypes to be applicable worldwide. We have produced a qPCR 
covering all genotypes using a conserved part of the N-gene. Compared with Matejusova our PCR 
performs equally well for genotype I, comparable or better for genotype II and III, and performs 
well for genotype IV which Matejusova’s does not recognize. When comparing the two PCR’s with 
cell culture our method is comparable to cell culture with regard to sensitivity for all genotype, 
sometimes being a log less sensitive. Matejusova’s were comparable with cell culture for genotype 
I, but slightly less sensitive for genotype II and III whereas genotype IV was not recognized in our 
assay.   
 
Questions: 
Sven M. Bergmann: Why does the cell culture perform better than the PCR? 
Søren Peter Jonstrup: A larger volume of supernatant is used to inoculate cells. When covering 
many genotypes the PCR might perform less effective on some isolates. 
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SESSION III: Scientific research update 
 
Progress in the development of seroneutralisation test (SNT) for detection of Cyprinid 
herpesvirus 3 (CyHV3) antibodies in carp, Cyprinus carpio. 
J. Castric, J. Cabon and L. Bigarré 
Unité de Pathologie Virale des Poissons, AFSSA-Ploufragan / Plouzané 
Technopôle Brest-Iroise, BP70, 29280 Plouzané, FRANCE 
 
Abstract: 
Koï Herpesvirus disease (KHVD caused by CyHV3) has a high economical impact on the carp 
farming industry throughout the world. PCR-based methods are recommended for the diagnostic of 
KHVD in clinically affected carp, but are poorly efficient when applied to the detection of viral 
genome in asymptomatic carriers. In those fish, the virus may remain latent and cause the spread of 
the virus to naïve populations. Serological techniques, mainly ELISA, have been developed in order 
to detect carp populations that have previously been experimentally or naturally exposed to CyHV3 
(ref). However, this method lacks specificity as observed by cross-reactions with carp pox 
herpesvirus (CyHV-1). For this reason, a seroneutralisation test (SNT) has been developed to detect 
the presence of fish antibodies directed CyHV-3 in experimentally infected carp. 
The test was performed in KF-1 cell line cultivated in microplates at 24°C under CO2 atmosphere. 
The carp plasma were diluted from 1/40 to 1/5120 and the SN reaction conducted for 16 to 18 hours 
at 24°C with 40 to 50 TCID50 of CyHV-3 (isolate 07/108b) per well.  The cells were then 
inoculated with the mixture virus and plasma and incubated for 8 to 10 days at 24°C under CO2 
atmosphere before fixation and staining. The reaction was considered specific since no cross 
reaction was observed with CyHV-1. The SNT was used to study the kinetics of anti-KHV 
antibodies in the plasma of 40 koï carp experimentaly infected per bath. Six months post-infection, 
the carps were individually marked and blood samples were then collected regularly during 18 
months; 45% of the plasma were found positive for CyHV3 antibodies at the beginning and at the 
end of the control, 25% remained negative during the 18 months of the study, 25% were found 
positive in the beginning of the control but negative by the end, and 5% were found doubtful. Those 
results indicate that antibodies against CyHV3 are still detectable in koï carp 2 years post-exposure 
to the virus.  
A comparison of the SNT used in this study with other serological techniques (ELISA, IFAT, 
Western-Blot) will be carried out in the frame a proficiency test planned in the SERO-KHV project 
of the European EPIZONE project. 
References 
Adkison M. A., Gilad O. and Hedrick R. P. (2005) An Enzyme Linked Immunosorbent Assay 
(ELISA) for detection of antibodies to the Koi Herpesvirus (KHV) in the serum of Koi Cyprinus 
carpio. Fish Pathology, 40 (2), 53-62. 
St Hilaire S., Beevers N., Joiner C., Hedrick R.P. and Way K. (2009) Antibody response of two 
populations of common carp, Cyprinus carpio L., exposed to koi herpesvirus. Journal of Fish 
Diseases, 32 (4), 311-320. 
 
 
Minutes: 
KHV can be quite difficult to detect even by the use of molecular methods. Therefore it is desirable 
to be able to detect KHV antibodies in the fish instead. In order to develop serologic techniques and 
to study the kinetics an infection trial was performed. 
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Infection trial: 2 days at permissive temperature of 23°C, then change in temp to 29°C or 10°C 
which is not permissive for the virus to help the koi to survive the infection and produce antibodies.  
The developed ELISA test is specific (no neutralisation of CyHV1 using plasma from fish infected 
with CyHV3 and vice versa). Antibodies can be found in fish for 2 years. 
 
Questions: 
François Leiffrig: Do you use serum or plasma? 
Laurent Bigarré: We use plasma. 
Sven M. Bergmann: You get similar results whether you use plasma or serum. 
Tomás Veselý: Do you keep the koi at the same temperature for 2 years? 
Laurent Bigarré: No. 
Niels Jørgen Olesen: The first blood sampling was 5½ month after infection. Did you try earlier? 
Laurent Bigarré: We could detect antibodies already after 1 month. 
Sven M. Bergmann: At 20°C you can detect antibodies already after 12 days. 
 
 
 
Vertical transmission - PD and ISA 
Brit Hjeltnes 
 
Abstract: 
In 2009 the Norwegian Food Safety Authorities asked the Norwegian Scientific Committee for 
Food Safety to perform a risk assessment on vertical transmission of notifiable diseases in Norway. 
In addition the committee was asked to include diseases under consideration for the national list of 
notifiable diseases and give advice on which diseases should be included in national surveillance 
programs. To prepare scientific background documents necessarily to answer the questions, the 
panel on Animal Health and Welfare established an ad hock group consisting of four experts. 
Infectious Salmon Anaemia Virus (ISAV), Infectious Pancreatic Necrosis Virus (IPNV), nodavirus, 
Salmonid Alphavirus (SAV), Flavobacterium psychrophilum, Piscirickettsia salmonis and 
Francisella philomiragia were assessed. Heart and Skeletal Muscle Inflammation (HSMI) was 
excluded from the assessment due to lack of information. 
 
The Committee used the OIE`s Aquatic Animal Health Code (2008) definition for vertical 
transmission:” Vertical transmission means the transmission of a pathogen from parent aquatic 
animal to its progeny via sexual products”. The risk of vertical transmission was assessed for 
Norwegian aquaculture and when disinfection procedures are carried out according to official 
Norwegian requirements and procedures. 
 
Based on the risk assessment, neither ISAV nor SAV were recommended to be included in 
Norwegian national surveillance programs.  
 
Minutes: 
The Norwegian scientific committee for food safety www.vkm.no was asked for a risk assessment 
on vertical transmission. The report in Norwegian can be found on the web. The OIE definition of 
vertical transmission was used, so it was not taken into account whether the pathogen was situated 
inside or outside the egg. The committee has looked at the question based on Norwegian procedures 
and aquaculture and not taken into account aquaculture procedures used in other countries. E.g. it 
was taken for granted that the farmers follow the procedures for disinfection prescribed by 
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Norwegian law. The information used for this report was scientific papers and open information 
from the industry.  
 
Salmonid alphavirus (SAV) 
Sea water: Outbreak and virus isolation from all sizes of fish, including broodstock.  
SAV positive broodfish: Eggs from SAV positive broodfish  was examined by Bratland & Nylund, 
2009: 
• 1/220 non fertilized eggs 
• 1/220 eyed eggs 
• 2/430 fry 
were positive for SAV by realtime-PCR. 
 
Detection of SAV in fresh water hatcheries: 
• 16/35 hatcheries positive by realtime-PCR (Nylund & Bratland, 2009) 
• 0/15 (2007), 0/10 hatcheries (2009), 0/35 (2007-2009) from endemic areas (PatoGen) 
• 0/46 hatcheries (Jansen et al, unpublished) 
• No positive findings after testing on brood fish and offspring in Ireland (Graham, pers. 
com.) 
• No evidence of SAV in fresh water based on findings at the National Veterinary Institute.  
• False positive pcr-results has been observed caused by 
o Vaccinated fish (PatoGen) 
o Contaminated sampling equipment (PatoGen) 
 
Experimental studies: 
• Vertical transmission of SAV2 reported after injection of brood fish (Castric pers. com.). 
Large amount of virus injected. 
• No evidence of vertical transmission after screening eggs and offspring of SAV3 positive 
brood fish. More than2000 samples analysed (Kongtorp et al, unpublished).  
 
Geographical evidence: 
• SAV1, 4, 5 and 6  in Atlantic salmon in seawater in Ireland and Scotland 
• SAV2 cases (sleeping disease) in rainbow trout in fresh water in several European countries 
• SAV3 in Norway 
• Different geographical distribution of different subtypes of SAV in Europe despite 
transportation of eggs during many years 
• SAV has not been detected in North America or Chile despite import of eggs from e.g. 
Norway.  
 
Conclusion: 
• In endemic areas in Norway the risk of brood fish being infected with SAV and become 
carriers are considered to be high 
• There are reports of egg and milt testing positive for SAV but this has not been confirmed 
by several other research groups 
• The risk of vertical transmission of SAV is regarded to be low 
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Infectious salmon anaemia (ISA) 
Eggs, embryo juveniles smolt and post smolt reported to test pos for ISAV in Norway by one 
research group who concluded that the most important route of ISA transfer is by vertical 
transmission. These finding have not been confirmed by other groups. 
 
Conclusion: Vertical transmission of ISAV cannot be excluded but is of minor significance in 
Norway. 
 
Questions: 
Eann Munro: Are broodfish routinely screened for PD and ISA? 
Hege Hellberg: No, not routinely but there has been a limited surveillance by the food safety 
authority. But the broodfish farmers may use private companies for screening.  
 
 
 
 
 
Heart and Skeletal Muscle Inflamation (HSMI) – an emerging disease in salmon, new results 
indicating a reovirus 
Irene Ørpetveit 
National Veterinary Institute 
 
Abstract: 
 
Heart- and skeletal muscle inflammation (HSMI) is a serious infectious disease of farmed Atlantic 
salmon, affecting young salmon 5-9 months after seawater transfer with up to 20% mortalities. 
HMSI was discovered in 1999, and since then, disease outbreaks have occurred in salmonid fish 
farms along the entire Norwegian coastline. The cause of the disease has long been unknown, 
although based on results from experimental challenges, a viral aetiology has been suspected. The 
results from pyrosequencing of total RNA from heart and serum samples from fish experimentally 
challenged with HSMI indicate that the disease is caused by a novel virus, provisionally called 
piscine reovirus (PRV). Pyrosequencing resulted in 90% coverage of the viral RNA, and subsequent 
Sanger sequencing and RACE indicate that the viral genome consists of 10 segments and a total of 
23 300 bp. Bioinformatic analysis revealed only 1,5 % identity with known reoviruses at the 
nucleotide level, and 54 % identity at amino acid level, indicating that the HSMI virus may 
represent a new genus. 
 
Minutes: 
 
Identification of a novel virus associated with HSMI. HSMI was first described in 1999. The 
disease has not been described in any other countries. All diagnostics is based on histology and 
pathology.  
 
Determination of disease agents has been pursued by 
• Cultivation 
• Classical molecular methods – consensus PCR 
• Lots of shots in the blind. 
• New technology: pyrosequencing. 
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Pyrosequencing is rather expensive. Extremely large amounts of data must be analyzed. It is 
difficult to obtain full length sequences. 
The project was initiates based on experimental challenge studies. Tissue from fish with HSMI 
induced clinical signs consistent with HSMI in infected fish. Pre-treatments of tissue from diseased 
fish had no effect – was that because the pathogen was a virus? 
 
Pyrosequencing: 
• Which organs to select? 
o Organs most likely to contain the agent 
o Organs which are likely to contain as few organisms as possible (avoid intestine) 
o For HSMI: heart and blood chosen 
• Sequence analysis implied the presence of an aquareovirus. 
• Mock-infected fish were negative 
• No other viruses were identified. 
• Viral genome: 23300 bp on 10 segments. 
• A provisional name for the virus is piscine reovirus (PRV). 
• Phylogeny: does not cluster with anything known – new genus? 
 
RT-qPCR: 
• Very high viral load in fish with HSMI 
• Low load in healthy fish 
• 104-106 times more viral load in diseased fish compared to healthy fish 
 
Diagnosis: 
• Several pcr methods developed 
• Antibodies against the virus are available 
 
The present work has been submitted for publication in PLoS One. 
 
Dr. Torstein Tengs at the NVI will be very interested in testing organs from other salmonids than 
rainbow trout and Atlantic salmon for this virus.  
 
Questions: 
Heike Schütze: Has the virus been seen by EM? 
Irene Ørpetveit: The group has not done any work with EM, but others claim they have, but it has 
not been published. 
Brian Dall Schyth: Was the sample DNase treated? What about DNA viruses? 
Irene Ørpetveit: I do not know if the samples were DNase treated. They isolated total RNA 
because mRNA from DNA viruses should be included. 
Eann Munro: We have isolated reovirus from a wild returning sea trout. 
Niels Jørgen Olesen: We have also isolated reovirus by cell cultures from Denmark and Iceland 
from fish without clinical signs. In China grass carp reovirus is causing severe mortality. It could be 
interesting to compare the PRV and grass carp reovirus. 
Irene Ørpetveit: I am sure Torstein will be interested in comparing these two reoviruses, and I will 
pass on the information.  
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Club 5 project: Epizootic Ulcerative Syndrome (EUS):  
Development and implementation of diagnostic methods 
Olga Haenen (CVI, NL), Birgit Oidtmann (CEFAS, UK, invited EUS expert), Søren Kahns (DTU Vet, DK), Eva 
Jansson (SVA, SWE), Thorbjörn Hongslo (SVA, SWE), Marc Engelsma (CVI, NL), Ineke Roozenburg (CVI, NL), 
Nicole Nicolajsen (DTU Vet, DK), Michal Voorbergen (CVI, NL), Anna Aspán (SVA, SWE), Anne Marie Lassen-
Nielsen (DTU Vet, DK), Niels Jørgen Olesen (DTU Vet, DK) 
 
Abstract: 
Epizootic Ulcerative Syndrome (EUS), caused by the oomycete fungus Aphanomyces invadans 
(A. piscicida), is a notifiable (OIE & EU) emerging (for EU exotic) disease of  >60 fish species in 
Asia, Australia, N-America, with a recent outbreak in the Zambezi River in Africa. EUS must, if 
introduced into the EU, be eradicated immediately. Since August 2008, all NRL’s for Fish Diseases 
of the EU should be able to diagnose EUS, but most have no Standard Operating Procedures (SOPs) 
and reference materials yet. Since the EUS workshop for NRL’s of Fish Diseases at Aarhus, June 
2008, CEFAS and the CRL for Fish Diseases worked together with the EUS OIE Reference 
laboratory in Bangkok. Although some tests for detection of A. invadans and diagnosis of EUS are 
described in scientific literature and in the OIE Manual, SOPs for the NRL’s for Fish Diseases are 
needed.  
This Club 5 project (by CVI, SVA and Vet DTU, with B.Oidtmann (CEFAS) as invited expert,  
Sept 2009-April 2011), aims to introduce the best confirmatory methods for EUS into the NRL’s 
for Fish Diseases of the EU, in collaboration with the OIE Reference laboratory in Bangkok:  
• Culture the reference strain at the participating labs first 
• Try out described EUS methods (fresh smears, fungus isolation, histopathology, PCR) and 
choose best methods for standardisation and SOPs 
• Develop alternative methods (e.g. immunohistochemistry, TaqMan PCR), and validate and 
implement them. 
• Establish an electronically available slide collection for EUS histopathology  
• Write SOPs for the best diagnostic tests for EUS based on our findings. 
 
A kick off meeting was held March 2010 at CVI of WUR, Lelystad, NL, which resulted in many 
action points. Division of tasks, activities, progress and plans will be presented in this lecture. 
 
Minutes: 
Aims of the project: To introduce the best confirmation methods for EUS to the NRLs  
 
Mansour El-Matbouli: We got a strain from ATCC that turned out not to be Aphanomyces 
invadans. 
Søren Kahns: This strain has now been withdrawn. I looked for A. invadans in ATCC and could 
not find it anymore. 
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Access to facilities within the Network of Animal Disease Infectiology and Research Facilities – 
NADIR. 
Torsten Snogdal Boutrup 
National Veterinary Institute, Technical University of Denmark  
 
Abstract: The NADIR project lies within the Seventh Framework Programme of the European 
Community, grant agreement no 228394 and is a project running from 2009-2012. It is focused on 
unifying and coordinating the interests of- and access to infectiology and research facilities in EU 
and collaborative states for all major groups of production animals, fish, pig, cattle, sheep, poultry 
and also mouse as the most widely used laboratory animal. 
Within the NADIR consortium fish-groups from three institutions participates. Veterinary Science 
Opportunities (VESO Vikan) Norway, Institut National de la Recherche Agronomique (INRA) 
France and National Veterinary Institute, Technical University of Denmark (DTU Vet) Denmark. 
The first part of the project has been to coordinate interests in respect to the overall NADIR project, 
and to collaborate on exchanging rainbow trout and salmon strains normally used for infection trials 
at the partnering institutions to be tested towards susceptibility to VHSV, IHNV, IPNV and PD.   
As of November 2009 access to the facilities at VESO Vikan and DTU Vet for European research 
groups to conduct infection trials at the facilities has been announced on the NADIR homepage; 
http://www.nadir-project.eu/nadir_project/call_for_access where details about access can be found. 
Access to the facilities is based on a preliminary application sent via the online application form on 
the homepage. Upon acceptance of the preliminary proposal a final application should be sent 
which is assessed by a scientific committee for review. Further the project leader in a proposed 
activity must be from a different European state than the one in which the activity is applied for.   
In between VESO Vikan and DTU Vet there is a broad opportunity to apply for conduction of 
infection trials on several fish species with a variety of pathogens; both viral, bacterial and parasitic 
and with manipulation of several physical and chemical water parameters. Access to the facilities 
typically include all or part of the expenses paid for travelling back and forth, board and wages, 
help to or performing infection trials, daily care, sampling and termination of the trial and 
depending on the type of setup some virological or other laboratory testing on sampled fish. 
 
Minutes: 
The NADIR project is divided into the following activities:  
NA, Network activities 
• Increase communication between partners 
• Exchange of knowledge, materials and methods 
 
RA, Research activities 
• To improve the service provided by the facilities 
• Characterization of animal and cell lines 
• Production of reference material 
• Development of animal models 
 
TA, Transnational access 
• To provide access for European research groups to infection facilities within the network 
• For the fish areas this means VESO Vikan and DTU Vet 
• This opportunity have been made available as of November 2009 and has been called for on 
the NADIR website  
• Access include 
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o VESO Vikan: 10 tank months (8 trials) 
o DTU Vet: approximately 1 month access to facility (3 trials to hand out) 
 Help to or performing  infection trials 
 Daily caretaking, sampling and termination of trial 
 Access to laboratory facilities, wet and dry 
 Some laboratory work and testing 
 Travelling expenses and staying for 1 person for 3 weeks 
Access is possible for  
• Research groups or consortium of research groups 
• Project leader must be from a different country than the facility in which the project is 
applied for 
 
Application 
• Application is done by online submission on the NADIR homepage 
• Preliminary application followed by  
• Final application 
• Both applications is reviewed by a scientific committee  
 
VESO Vikan 
• Access to different sizes of tanks 
• The following fish species can be included: 
o Atlantic salmon  
o Sea bass 
o Cod  
o Rainbow trout 
o Many others 
• Experience with a broad range of pathogens 
 
DTU Vet 
• Mainly small tanks 
• Both fresh and salt water 
• Fish species 
o Rainbow trout 
o Also salmon 
o Pikeperch 
o Pike 
o Saltwater species 
• Experience with mainly VHSV, IHNV, but also Aeromonas salmonicida, Yersina ruckeri, 
Flavobacterium psychrophilum  
• Only limited experience in parasites 
 
Questions: 
Brit Hjeltnes: I am a bit negative towards the limitations of the groups that can apply, e.g. a Danish 
group cannot apply to do anything at DTU Vet, and a Norwegian group can do nothing in VESO 
Vikan.   
Torsten Snogdal Boutrup: This was a very strong point in the EU application. This should be an 
opportunity for countries not having access to research facilities. This is also to encourage 
cooperation between countries. It shall, however, be underlined that colleagues from the host 
country cannot be leader of the proposal, but are most welcome as participant in a consortium. 
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Perch Rhabdovirus infection in farmed pike-perch and perch – an emerging disease  
L. Bigarré, J. Cabon, M. Baud and J. Castric 
Pathologie Virale des Poissons, AFSSA, Technopôle Brest-Iroise, 29280 Plouzané, France 
 
Abstract: 
Perch (Perca fluviatilis) an pike-perch (Sander lucioperca) are increasingly used in aquaculture in 
Europe since they represent an interesting alternative to diversify the market of fish products. 
Consequently, infectious diseases should have an increasing impact on the production, unless 
strategies for control are urgently developed. Among the pathogens of importance, rhabdoviruses 
are already responsible for serious losses of fry in farms, for instance in France, Ireland and 
Denmark. Often, the viral contaminations are introduced in the farm by the capture of genitors or 
eggs from the wild. Specific and sensitive diagnostic tools are urgently needed to select genitors 
free of virus and prevent vertical dissemination.  
However, poor data are available concerning percids rhabdovirus populations (2, 3). Our 
preliminary results indicate that at least two distinct rhabdoviruses, belonging to the vesiculovirus 
genus, are found in percids in France, and supposedly in Europe. Furthermore, some molecular 
relations have been found between perch vesiculoviruses and isolates from other fish species, such 
as sea trout (Salmo trutta)(1, 4), suggesting horizontal transmission between various hosts in the 
wild. 
More isolates from Europe should be studied for a more comprehensive inventory of the viral 
populations, both in farms and in the wild. This is a prerequisite for developing serological tests and 
PCR probes.  
With several European partners, we propose to tackle this goal in a project called ViPer (Virus of 
Percids).  
 
1. Betts, A. M., D. M. Stone, K. Way, C. Torhy, S. Chilmonczyk, A. Benmansour, and P. 
de Kinkelin. 2003. Emerging vesiculo-type virus infections of freshwater fishes in Europe. 
Diseases of Aquatic Organisms 57:201-12. 
2. Dannevig, B. H., N. J. Olesen, S. Jentoft, A. Kvellestad, T. Taksdal, and T. Håstein. 
2001. The first isolation of a rhabdovirus from perch (Perca fluviatilis) in Norway. Bulletin 
of the european association of fish pathologists 21:186-194. 
3. Dorson, M., C. Torchy, Chilmonczyk S, P. de Kinkelin , and C. Michel. 1984. A 
rhabdovirus pathogenic for perch (Perca fluviatilis L.): isolation and preliminary study. 
Journal of Fish diseases 7:241-245. 
4. Johansson, T., S. Nylund, N. J. Olesen, and H. Bjorklund. 2001. Molecular 
characterisation of the  nucleocapsid protein gene, glycoprotein gene and gene junctions of 
rhabdovirus 903/87, a novel fish pathogenic rhabdovirus. Virus Res 80:11-22. 
 
 
Minutes: 
 
Perch and pike perch are tasty fish and a traditional high value niche product. The fish are 
moderately tolerant to environmental conditions. The global production is very small compared to 
trout, capture 30.000 tons, aquaculture 300 tons per year. There is a need to understand better the 
reproduction parameters (light, temperature, food etc.). Diseases: bacteria, parasites etc. 
Rhabdoviruses (mild to heavy losses). 
Until now, no complete genome of the percid rhabdoviruses have been sequenced. In the literature 
there is only poor data concerning percid rhabodoviruses, less than 10 papers are published. The 
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first outbreak caused by percid rhabdovirus occurred in a laboratory in France in 1980 (Dorson et 
al. 1980) 
Outbreaks have also occurred in Ireland, Denmark, Norway and other countries. Percid rhabdovirus 
belong to the vesiculoviruses. 
No efficient PCR test has yet been published. There are serological reagents available but methods 
are not standardised between laboratories. 
Healthy fish from the wild are viral reservoirs. The farmers use wild fish as brood fish or collects 
eggs in the wild. There may be high mortality in the fry.  
 
The viral population 
• Serology 
o Strong relationship between the original isolate from perch in France and pike from 
Denmark and pike-perch from France. The Danish isolate from pike had moderate 
relations with perch from Norway and lake trout form Finland.  
o There is a need to develop serologic reagents 
• Molecular methods 
o A small domain in the L-gene has been sequenced (Batta et al. 2003) and the perch 
isolate is different from SVCV, PFRV and lake trout rhabdovirus. Two isolates from 
pike from Denmark were quite different. More sequences are needed and from other 
regions. 
o Full G-gene has been sequenced from 8 isolates from 1980 to 1999 from perch and 
sander. These isolates fall into genogroup IV. 
o Another isolate from France is completely different from the others and fall into 
genogroup I with lake trout rhabdovirus.  
• How many viruses and how many hosts?  
o At least 2 viruses, possibly more and several hosts. 
o There is a need of molecular data to identify the viral population 
 
Viper project: The project has is collaboration between France, Denmark, Sweden and Finland. If 
granted through EMIDA it will run for 2 years.  
The aims are to  
• acquire genetic data from European rhabdovirus collections by sequencing.  
• design probes for qPCR.  
• develop and standardise serologic tools. 
• suggest egg disinfection assays not to introduce the virus from the wild to farms 
 
 
Questions: 
Olga Haenen: About 15 years ago we isolated a rhabdovirus from roach. It was not pathogenic to 
pike any more, but had fully adapted to cyprinids, which got diseased after artificial induced 
infection. Are you planning to do infection experiments like this? 
Laurent Bigarré: Yes, we are also planning to do infection trials. 
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MicroRNA regulation as a future diagnostic tool 
Brian Dall Schyth, 
National Veterinary Institute, Denmark 
 
Abstract:  
MicroRNAs belong to a family of small noncoding RNAs which have emerged as important 
regulators of gene expression. These are initially transcribed as longer single stranded RNA species 
which fold up into stem loop structures. They are subsequently modified to generate mature 21-25 
bp long double stranded microRNAs, of which one or both strands show complementarity to sites in 
target mRNA(s). In the targeting process the microRNA is used by a large protein assembly called 
the RNA Induced Silencing Complex (RISC) to find and inhibit transcription by either blocking or 
cleaving the mRNA target. The fate of the mRNA is probably dependent on the degree of 
complementarity between the microRNA and the target. Vertebrates have more than 1000 different 
microRNAs and computational predictions point to that there are single microRNAs having more 
than 100 different target genes. Accordingly, microRNAs are expected to have a role in gene 
regulation in various situations including disease and immune response which has been verified in 
mammals and invertebrates. Our aim is to describe and explain regulation of microRNAs during 
infections with the rhabdovirus Viral Hemorrhagic septicaemia virus (VHSV) in rainbow trout. In 
addition, we want to describe co-regulation with other genes in combination with bioinformatics 
and work in cell cultures in order to elucidate the immune state at which microRNAs are regulated 
and if possible target connections. A perspective of this work is the use of microRNAs as 
diagnostics for immune or disease state, of vaccine or adjuvant potency and perhaps as a diagnostic 
of pathogens identity if pathogen specific microRNAs can be identified.         
 
Minutes 
Same probes can be used for most animals and humans as the microRNAs are very conserved.  
When you want to examine for microRNAs you have to extract using kits that will give you these 
small RNAs (21-25 bp). For doing the PCR you have to extend the size of the microRNA to be able 
to stuff in some primers.  
In rainbow trout during immune response we have a significant up-regulation of microRNAs. More 
specific diagnosis of pathogen type will probably be restricted to cases where the microRNA is 
produced by the pathogen itself – evidence from DNA viruses. It seems that the L-polymerase is 
targeted by the microRNAs associated with VHSV infection by bioinformatics approach.  
 
Questions: 
Hege Hellberg: It would be interesting to determine the point/time of infection? 
Brian Dall Schyth: Yes - the time of infection and the stage of infection vary for the fish we 
investigated, but we tried to keep it at a minimum by choosing fish which showed first signs of 
disease although we do realize that this mean that we will mainly find regulated microRNAs 
indicative of late stage of infection. But it is a good idea to relate microRNA regulation to the level 
of virus as an indicator of age of infection. But this can only be an indicator. It is hard to determine 
directly the time of infection as this may vary between fish being challenged together. 
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SESSION IV: Update from the CRL 
 
Results and outcome of the Inter-laboratory Proficiency Test 2009 
Søren Kahns, Nicole Nicolajsen, Maj-Britt Christophersen, Helle Frank Skall and Niels Jørgen Olesen 
Community Reference Laboratory for Fish Diseases, Technical University of Denmark, Aarhus, Denmark 
 
Abstract:  
A comparative test of diagnostic procedures was provided by the Community Reference Laboratory 
(CRL) for Fish Diseases to 36 National Reference Laboratories (NRLs) in the start of September 
2009. The test was prepared and tested according to protocols accredited under DS/EN ISO/IEC 
17025 and ILAC-G13:08/2007 standards. The test contained five coded ampoules. Four contained 
viral haemorrhagic septicaemia virus (VHSV) genotype Ie and IVa, infectious haematopoietic 
necrosis virus (IHNV) genogroup L and epizootic haematopoietic necrosis virus (EHNV), 
respectively. Furthermore, one ampoule did not contain any virus, only medium. The proficiency 
test was designed to primarily assess the ability of participating laboratories to identify the 
notifiable fish viruses VHSV, IHNV and ENHV (all listed in Council Directive 2006/88/EC). It was 
decided at the 13th Annual Meeting of the NRLs for Fish Diseases in Copenhagen 26-28 May 2009, 
that testing for EHNV for the first time should be included in this test. 
Participants were asked to titrate the viruses to assess the cell susceptibility for virus infection in the 
respective laboratories. Participants were encouraged to use their normal standard laboratory 
procedures. However, the identification should be performed according to the procedures laid down 
in Commission Decision 2001/183/EC using monolayered cell cultures followed by e.g. 
neutralisation test, immunofluorescence, ELISA or PCR. If ranaviruses should be present in any of 
the ampoules, it was mandatory to perform a sequence analysis of the isolate in order to determine 
if the isolate is EHNV.  
 
Outcome of Inter-laboratory Proficiency Test 2005: Identification of content: 24 laboratories out of 
36 correctly identified all viruses in all ampoules. Three laboratories identified the virus in ampoule 
I only as a ranavirus. 6 laboratories identified a virus in one or more ampoules that were not 
present. Two laboratories did not identify virus in one or more ampoules where a virus was present. 
Finally, one laboratory did not submit their results.  
Methods applied: The general trend was that laboratories which applied more tests to identify 
samples, scored higher than those, which relied on fewer types of laboratory tests. 24 laboratories 
used ELISA for identification of viruses, 21 used IFAT, 11 used neutralisation tests, 34 used PCR 
and 30 laboratories performed sequencing for identification of viruses. 29 laboratories used BF-2 
cells, 34 used EPC cells, 12 used RTG-2 cells and 10 used FHM cells. 
 
Concluding remarks: EHNV was included in the proficiency test and 28 participants were able to 
correctly identify the virus. This is considered to be a relatively large number of participants as it is 
the first time EHNV is part of the test and because identification of the virus include sequence 
analyses which has not been mandatory to use in previous tests. Nevertheless, EHN is a listed 
disease and all laboratories are obliged to implement diagnostic tools for identifying EHNV as soon 
as possible. Laboratories are encouraged to use a combination of cells as described in Commission 
Decision 2001/183/EC. However, the bad performance in several laboratories of their RTG-2 cell 
lines for growth of VHSV is worrying as is it described in Commission Decision 2001/183/EC that 
RTG-2 cells can be used instead of BF-2 cells. Based on these observations, laboratories are 
recommended to use BF-2 cells and not RTG-2 cells for replication/survey of/for VHSV. In 
general, it is recommended that participants evaluate the sensitivity of their cells lines in relation to 
the diagnostic purpose. 
 
The results of the proficiency test will be further discussed at this presentation.  
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Minutes 
Not many laboratories using PCR methodology are accredited we can only encourage laboratories 
to become accredited.  
In the forms of the proficiency test we asked a number of questions on which methods you used in 
order to be able to better understand why things sometimes go wrong. Unfortunately it was not 
possible to make definite conclusions based on this. Many wrong results seem to occur because of 
cross contamination events. 
It was surprising that only few laboratories subcultivated sample V, as it did not contain any 
viruses. According to the Commission Decision 2001/183 laboratories have to subculture once if no 
CPE can be observed in cell cultures 7 days after inoculation.  For the future we recommend 
laboratories to do so, also in proficiency tests. 
EHNV replicates well on EPC and BF-2 cell lines. VHSV replicates well on BF-2 cells and IHNV 
on EPC and FHM cells. So the combination of BF-2 and EPC cells seems to be a good combination 
for VHSV, IHNV and EHNV. But each laboratory has to look on their own cell lines and judge 
which cell lines will be the best for them to use.  
If relevant the CRL provided the laboratories with comments on how they fared in the test. This 
provided us with a lot of response and good feedback. The possibility for providing comments will 
also be used in future tests. 
The audience was asked if they have any comments, remarks or proposals for improvement of the 
proficiency test. No direct replies were given and this taken as a sign of satisfying form and 
performance of the proficiency test 2009. 
 
The next ring test will also include ISAV and KHV.  
 
Questions: 
Irene Ørpetveit: You say VHSV grow better on BF-2 than EPC cells. In Norway we saw that 
genotype III grew better on EPC cells. 
Niels Jørgen Olesen: It also seems that genotype IV grows better on EPC cells. It can vary from 
isolate to isolate but by using a combination of cells you should be able to identify any viruses. 
Niels Jørgen Olesen: Were cross contaminations mainly seen in laboratories using PCR directly on 
the ampoules? 
Søren Kahns: No, cross contaminations were not only caused by PCR as some of the laboratories 
that were reporting virus in ampoule V did observe CPE and titres on 96-well plates. 
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FishPathogens.eu 
Søren Peter Jonstrup 
Community Reference Laboratory for Fish Diseases, Section for Fish Diseases, National Veterinary Institute, 
Technical University of Denmark, Denmark 
 
Abstract: 
FishPathogens.eu was launched at last annual meeting with a database on VHSV. This database has 
now grown to include around 400 public available VHSV isolate reports and 250 sequence reports. 
Almost 100 persons have registered as users and 13 of these have reports stored in the database. 
Earlier this year an IHNV extension was revealed. In this talk I will give a brief overview on what 
has happened with the database since last annual meeting. 
 
Minutes: 
 The number of registered users has risen from 14 last year to now 95. The number of visits seems 
to be stabilizing around 400 per month. Around 1/3 of the visits during the last 3 months has been 
from USA. Denmark accounts for around 1/5 of the visits,. There are also a lot of visits from Asia. 
The number of VHSV reports has doubled since last year. The IHNV database has just been 
launched.  
Future databases are planned: SVCV in collaboration with Dr. David Stone from CEFAS, ISAV in 
collaboration with Dr. Mike Snow, Marine Scotland and KHV in collaboration with Dr. Marc 
Engelsma from CVI, Lelystad. 
We hope soon to be able to include online phylogeny in cooperation with bluetonguevirus.org. 
 
Questions: 
Irene Ørpetveit: The phylogeny will it be using default algorithms? 
Søren Peter Jonstrup: Yes, the algorithms will be default, but we hope you can be able to choose 
different parts of the virus genomes. Maybe there will be a possibility to choose between 2 
algorithms. Presently only DNA but not proteins are planned to be used for making phylogenetic 
trees. Proteins are included in the database, though.  
Niels Jørgen Olesen: In order to secure the existence of database in the future it is linked to the 
CRL function. 
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CRL achievements in 2009  
Søren Kahns, Nicole Nicolajsen, Helle Frank Skall, Søren Peter Jonstrup and Niels Jørgen Olesen 
Community Reference Laboratory for Fish Diseases, Technical University of Denmark, Aarhus, Denmark 
 
I. LEGAL FUNCTIONS AND DUTIES 
The functions and duties of the Community Reference Laboratory are described in the Council 
Directive 2006/88/EC Annex VI part I  
II. CRL OBJECTIVES FOR THE PERIOD JANUARY - DECEMBER 2009 
1. Organise and prepare for the 13th Annual Meeting for the National Reference Laboratories 
for Fish Diseases in 2009 (most likely to be held at the DTU National Veterinary Institute 
Department in Copenhagen, Denmark in May 2009). 
2. Produce a report from the Annual Meeting 2009. 
3. Collect data on the fish disease situation in EU, including all the listed non-exotic fish 
diseases given in Council Directive 2006/88/EC Annex IV Part 2  
4. Identify and characterise selected isolates of listed viruses (serological and genetic 
characterisation) 
5. Production of antisera against selected isolates when necessary. 
6. Assessment and standardisation of Real-Time PCR tests for the diagnosis, identification and 
typing of the listed non-exotic fish diseases. 
7. Develop, update and maintain the new EU Community Reference Laboratory for Fish 
Pathogens Database. A database created in order to collate all available information of 
isolates of listed fish pathogens including their origin, their sequences and their geographical 
coordinates  
8. Update and maintain a library of isolates of Infectious salmon anaemia virus (ISAV), Viral 
Haemorrhagic Septicaemia virus (VHSV) and Infectious Haematopoietic Necrosis virus 
(IHNV), Spring Viraemia of Carp virus (SVCV) and Koi Herpes virus (KHV) 
9. Preparation and standardisation of control reagents for use in PCR tests. Assessment of viral 
inactivation and viability of standard reagents for use as reference material in molecular 
tests. 
10. Organise a workshop in the implementation of Council Directive 2006/88/EC (to be 
organised back to back with the 13th Annual Meeting). 
11. Update the new webpage for the CRL. 
12. Supply standard antisera and other reference reagents to the National Reference 
Laboratories in Member States. 
13. Prepare the Annual Inter-laboratory Proficiency Test year 2009 for the National Reference 
Laboratories.  
14. Collate and analyse information gained from the Inter-laboratory Proficiency Test  
15. Facilitate and provide training in laboratory diagnosis.  
16. Attending missions, international meetings and conferences. Missions will focus on 
accession countries and OIE reference laboratories on listed exotic and non-exotic fish 
diseases. 
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CRL workplan for 2010 – ideas and plans for 2011 
Niels Jørgen Olesen, Nicole Nicolajsen, Helle Frank Skall, Søren Peter Jonstrup, Torsten Boutrup  
and Søren Kahns 
Community Reference Laboratory for Fish Diseases, Technical University of Denmark,  
Aarhus, Denmark 
 
OBJECTIVES FOR THE PERIOD JANUARY - DECEMBER 2010 
 
1. Organise and prepare for the 14th Annual Meeting for the National Reference Laboratories 
for Fish Diseases in 2010. 
2. Produce a report from the Annual Meeting 2010. 
3. Collect data on the fish disease situation in EU, including all the listed non-exotic fish 
diseases given in Council Directive 2006/88/EC Annex IV Part 2  
4. Identify and characterise selected isolates of listed viruses (serological and genetic 
characterisation) 
5. Production of antisera against selected isolates when necessary. 
6. Assessment and standardisation of Real-time PCR tests for the diagnosis, identification and 
typing of the listed non-exotic fish diseases. 
7. Expanding www.fishpathogens.eu with IHNV, SVCV and the inclusion af KHV and ISA 
will be initiated. 
8. Update and maintain a library of isolates of Infectious Salmon Anaemia virus (ISAV), Viral 
Haemorrhagic Septicaemia virus (VHSV) and Infectious Haematopoietic Necrosis virus 
(IHNV), Koi Herpes virus (KHV) and enzootic haematopoietic necrosis virus (EHNV). 
9. Update the webpage for the CRL, www.crl-fish.eu 
10. Update and include standard operating procedures on the CRL web page for the listed exotic 
and non-exotic diseases 
11. Workshop on available kits and reagents for diagnosis of the listed non-exotic diseases 
VHS, IHN, ISA and KHV including consideration of their sensitivity and specificity. 
12. Supply standard antisera and other reference reagents to the National Reference 
Laboratories in Member States. 
13. Inclusion of SOP´s on serological methods for detection of fish antibodies against VHSV, 
IHNV and KHV on CRL website, and introducing the methods in new Commission 
Decision on sampling and diagnostic procedures   
14. Prepare the Annual Inter-laboratory Proficiency Test year 2010 for the National Reference 
Laboratories. The test will be expanded to also include ISAV and KHV.  
15. Collate and analyse information gained from the Inter-laboratory Proficiency Test  
16. Establish diagnostic methods for diagnosis of EUS and assess the possibilities for including 
Aphanomycis invadans in proficiency test in future.  
17. Facilitate and provide training in laboratory diagnosis.  
18. Attending missions, international meetings and conferences. Missions will focus on NRLs 
where on-site communication would be beneficial. And to reference laboratories on listed 
exotic and non-exotic fish diseases in order to be updated on diagnostic methods. 
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OBJECTIVES FOR THE PERIOD JANUARY - DECEMBER 2011 
 
1. Organise and prepare for the 15th Annual Meeting for the National Reference Laboratories 
for Fish Diseases in 2011. 
2. Produce a report from the Annual Meeting 2011. 
3. Collect data on the fish disease situation in EU, including all the listed non-exotic fish 
diseases given in Council Directive 2006/88/EC Annex IV Part 2.  
4. Identify and characterise selected isolates of listed viruses (serological and genetic 
characterisation). 
5. Production of antisera against selected isolates when necessary. 
6. Assessment and standardisation of Real-time PCR tests for the diagnosis, identification and 
typing of the listed non-exotic fish diseases. 
7. Update and expand www.fishpathogens.eu with other pathogens. 
8. Update and maintain a library of isolates of Infectious salmon anaemia virus (ISAV), Viral 
Haemorrhagic Septicaemia virus (VHSV) and Infectious Haematopoietic Necrosis virus 
(IHNV), Koi Herpes virus (KHV) and enzootic haematopoietic necrosis virus (EHNV). 
9. Update the webpage for the CRL, www.crl-fish.eu 
10. Establish and maintain a library of tissue material from infected fish. 
11. Update the diagnostic manuals for the listed diseases on the CRL web page. 
12. Include diagnostic manuals for EUS on the CRL web page. 
13. Supply standard antisera and other reference reagents to the National Reference 
Laboratories in Member States. 
14. Perform molecular epidemiology analysis to improve knowledge on diseases spreading 
mechanisms of viral pathogens  
15. Prepare the Annual Inter-laboratory Proficiency Test year 2011 for the National Reference 
Laboratories. The test will include VHSV, IHNV, EHNV, ISAV and KHV.  
16. Collate and analyse information gained from the Inter-laboratory Proficiency Test  
17. Update diagnostic methods for diagnosis of EUS and assess the possibilities for including 
Aphanomycis invadans in proficiency test in future.  
18. Facilitate and provide training in laboratory diagnosis.  
19. Establish and offering a yearly training course in methods used for diagnosis of fish 
diseases, at the CRL laboratory facilities. The content will depend on request from 
participants 
20. Organizing missions to relevant laboratories. Missions will focus on NRLs where on-site 
communication would be beneficial. 
21. Attending missions, international meetings and conferences in order to be updated on 
diagnostic methods on listed exotic and non-exotic fish diseases.  
 
Minutes  
The diagnostic manuals that will be published on the CRL webpage are mandatory to follow and 
not guidelines as the OIE manuals. Regarding EUS it may end up with that surveillance will be 
passive and in case of suspicion the recommendation will be to send it to specific laboratories as it 
is very costly if all laboratories shall be able to diagnose the disease. 
The CRL will offer a yearly training course in fish diagnostics primarily to the staff of the NRLs for 
fish diseases. The course will take place in the laboratories of the CRL. The date has not been 
decided yet but might be in November 2010 for. The exact date will be advertised before the 
summer holiday. The topic of the course has not been decided yet, it depends on the needs of the 
participants - if you have ideas or needs for courses, please tell us.  
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We also encourage you to provide us with suggestions for the next year’s CRL work plan. The 
NRLs actually have to accept the CRL work plan. The work plan must be approved by the 
Commission by 1 September. The NRLs can propose and decide plans for the CRL.  
Workshop on epidemiology and risk assessment? Should we perform an independent EU workshop 
on this topic in collaboration with ISAE, e.g. in spring 2011. If there is interest we can hopefully 
persuade the Commission to support this.  
 
Questions: 
Marc Engelsma: It is quite interesting to hear that you will be obliged to use the tests found on the 
webpage. I think if we have fixed tests you may have problems after 2 years due to the 
developments of better diagnostic tests. 
Niels Jørgen Olesen: You are already obliged to use specific tests, but it is and will also be written 
that you can use test with proven similar or better standards. It also has to do with trust in trade. 
Giuseppe Bovo: The official manuals are very important for accreditation. I think there may be a 
problem if these tests are on the web, and not in the legislation. 
Sigrid Cabot: We are still working on this decision. If accepted it will be stated in the decision that 
the manuals can be found on the webpage, and of course it shall be written on the webpage that this 
is based on the decision. It will be easier to update a homepage than the legislation. Another issue, 
after the entry into force of the Lisbon treaty, the European Community is replaced by the European 
Union, which means that we from now on refer to European Union Reference Laboratories (EU-
RLs) instead of Community Reference Laboratories (CRLs), and that in the titles of the EU 
legislation it will be references such as the following: Regulation (EU) No 175/2010. 
 
Brit Hjeltnes: The National Veterinary Institute in Norway has together with Prince Edward Island 
been recognised as an OIE Collaborating Center in Aquaculture Epidemiology. This collaborating 
centre might be interested in participating in an epidemiology workshop. 
 
Niels Jørgen Olesen: What about the CRL training courses – are there any needs? 
Snjezana Zrncic: We would be interested in a CRL training course in molecular diagnosis. 
Søren Kahns: We will send out suggestion of the content of the training course and will like you to 
respond back on your needs. 
 
Niels Jørgen Olesen: 15th annual meeting. Are there suggestions for date, place and need for a 
workshop? It is very important we get feedback on when other meetings, conferences etc. are 
planned. Please also shout out the date of the Annual Meeting to others when decided so that other 
meetings are not placed at the same date. The Norwegian participants prefer not to have the meeting 
on the 17 May. In the autumn is not preferred as there are a lot of conferences.  
Reply: The general opinion was the same date next year as this meeting was OK.  
 
Niels Jørgen Olesen: Regarding venue of the 15th AM, suggestions are Copenhagen, Aarhus, at 
IZSVe, Padova in Giuseppe Bovos laboratory in Italy or at CVI in Lelystad at Olga Haenen. The 
nice thing about Århus is that you can all meet all our technicians but we realise that the access to 
Århus is not so easy. Marine Laboratory, Aberdeen is just about to finish their new lab, so it could 
be nice to visit them.  
Reply: Regarding venue, people did not want to go to Brussels. Conclusion was that it was up to 
the CRL to decide. 
 
Niels Jørgen Olesen: Regarding the workshop about kits, how can we be better to share knowledge 
regarding the usability of the kits? The primary aims of these meetings are to harmonize the 
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diagnostic methods used and to improve the health of European aquaculture. So I am very happy 
that we covered so many diseases during the meeting.  
Lot of thanks to Nicole Nicolajsen for all the work made on arranging this meeting. Thanks to our 
technicians for organising the drinks reception.  
 
 
 
Pictures 
Guiseppe Bovo, Olga Haenen, Vlasta Jencic and Nicole Nicolajsen were excellent photographers 
during the workshop. For pictures from the workshop please have a look at our web page. 
http://www.crl-fish.eu. 
 
 
